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Abstract 
Background: The nation’s HIV infection rate is alarming, yet only a small percentage of eligible 
individuals are prescribed pre-exposure prophylaxis (PrEP). This sluggish PrEP uptake may be 
related to lack of knowledge among non-HIV specialist providers. Thus, interventions to expand 
providers’ use of PrEP as an HIV prevention strategy are needed. 
Objectives: The project aim was to develop an intervention to improve retail nurse 
practitioners’ (NP) knowledge for PrEP clinical practice, comfort screening for “at-risk HIV” 
patients, confidence prescribing PrEP, and likeliness to prescribe PrEP in the next six months. 
Methodology: An online PrEP tutorial was implemented for retail clinic NPs. There were three 
phases: pre-survey, post-survey, and 30-day retention survey. Paired t-tests for differences 
between the pre- and post-surveys were performed. ANOVA was conducted to test differences 
between pre-, post-, and 30-day retention surveys. 
Results: Paired t-tests revealed significant differences between pre- and post-surveys for 
knowledge, comfort, confidence, and likeliness to prescribe (p <.05). Similarly, the repeated 
measures ANOVA revealed a significant main effect of the intervention on all constructs (p 
<.05). Post-hoc analysis showed all constructs, except for comfort, increased between the pre- 
and post-surveys and all constructs increased between pre- and retention surveys. There were no 
differences between post- and retention surveys for any constructs. 
Conclusion: By increasing knowledge related to PrEP, online education can improve NPs 
consultation and prescribing practices to help confront the HIV epidemic. 
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The PrEP Education Intervention 
According to the Centers for Disease Control and Prevention ([CDC], 2020a), there were 
37,832 individuals in 2018 that were newly infected with the human immunodeficiency virus 
(HIV), accounting for more than 1.1 million HIV positive Americans. Despite the overall steady 
decline that was noted in the past decade, the recent trend of increased HIV diagnoses was most 
notable in the South, with 51% of the nation’s new infections (CDC, 2019a). The recently 
launched national program, “Ending the HIV Epidemic: A Plan for America,” with its mission to 
reduce 75% of HIV infections in the next five years and 90% by the year 2030, is intended to 
refuel the national effort to end this epidemic (HIV.gov, 2019). Specifically, the “Plan for 
America” is a national movement to decrease new HIV transmissions by increasing the uptake of 
the Food and Drug Administration (FDA) approved antiretroviral therapy (ART). Rationales for 
the plateaued HIV infection rate included the lack of access, uptake, and adherence to PrEP 
(Pinto et al., 2018).  Thus, recent studies have carefully examined the existing barriers, including 
provider knowledge, comfort, and confidence along with patient access and cost (Clement et al., 
2018; Edelman et al., 2019; Henny et al., 2019b; Pinto et al., 2018) that impact the uptake of 
daily pre-exposure prophylaxis (PrEP) for “at-risk HIV” individuals. 
Background and Significance 
Although the United States had an 11% decline in HIV incidence rates from 2010 
through 2017, annual increases in certain groups of the population have recently been detected 
(CDC, 2020a). Gay, bisexual, and men having sex with men (MSM) groups of individuals were 
most affected, representing 69% of new HIV cases in 2018 (CDC, 2020a). For the same year, 
24% of the diagnoses were from heterosexual individuals, and 7% were from injection drug 
users (CDC, 2020a). 
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  Despite the screening strategies and advances with antiretroviral therapies, it was 
alarming that the nation’s southern states were disproportionately represented, with almost 
20,000 new HIV diagnoses in 2017 (CDC, 2019b). The 16 states and Washington, District of 
Columbia (DC) that make up the southern region of the nation, presented with the most 
significant burden of HIV and HIV related deaths. Washington, DC had the highest HIV 
incidence rate (46.3%), followed by Georgia and Florida, with rates of 24.9% and 22.9%, 
respectively (CDC, 2019b). Comparing for the same 2017-year, Virginia Department of Health’s 
(2018) HIV incidence rate for Virginia was 10.4% with urban areas like Alexandria and 
Arlington counties with 19.4% and 14%, respectively. Many of these infections were notable 
among the urban areas. It is worth mentioning, however, that 24% of new diagnoses of HIV in 
the southern region in 2017 were reported from suburban and rural areas (CDC, 2019a).  
Preexposure Prophylactic Therapy 
The combination of tenofovir disoproxil fumarate (TDF) 300 mg and emtricitabine (FTC) 
200 mg, which received FDA approval in 2012, was known to be highly effective for prevention 
of HIV (CDC, 2019d). As a single daily pill, known as Truvada, the efficacy of PrEP had been 
well documented to exceed 92% with consistent usage in multiple studies (CDC, 2019d; U.S. 
Preventive Task Force [USPTF], 2019; Zhang et al., 2019). Indeed, the CDC’s 2017 PrEP 
Clinical Practice Guideline (CPG; CDC: U.S. Public Health Service, 2018) presented 
overwhelming evidence of PrEP’s high efficacy and safety demonstrated through high quality 
randomized clinical trials. Additionally, a CDC report predicted that a 40% increased uptake of 
PrEP, over ten years, may potentially prevent 33% of new infections among the MSM 
subpopulation (Huang et al., 2018). 
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As reported by the well-known iPrEX clinical trial, the CDC supported the iPrEX 
modeling to predict a 99% reduction in the risk of HIV if Truvada was taken every day of the 
week (Anderson et al., 2012). Numerous research studies supported the safety and efficacy of the 
FDA approved PrEP (CDC: U.S. Public Health Service, 2018; Clement et al., 2018; Henny et al., 
2019; Wilson et al., 2020; Wood et al., 2018; Zhang et al., 2019). Recently, the USPTF (2019) 
updated its final recommendation to offer the “A” rating for PrEP, declaring substantial net 
benefit of risk reduction for individuals with high HIV risk. Hence, researchers continued to 
question why prescriptions for PrEP have been lagging, despite its proven efficacy to reduce the 
risk of HIV transmission. 
Purview Paradox and PrEP Affordability  
Experts identified one of the critical barriers to successful PrEP implementation to be the 
“purview paradox.” This notion suggested that neither infectious disease (ID) physicians nor 
primary care providers (PCPs) believed PrEP to fall within their specific scope of practice (Pinto 
et al., 2018). ID specialists had treated individuals with HIV diagnosis, while PCPs had not been 
familiar with HIV-related pharmacotherapy or management. For many years, the debate over 
identifying the appropriate providers to prescribe PrEP ensued while addressing the affordability 
of Truvada. These factors were previously studied to explain the less-than-optimal PrEP 
prescribing patterns (Edelman et al., 2019; Pinto et al., 2018; Zhang et al., 2019). 
Although the high cost of Truvada has posed a barrier for those without health plans, the 
“Patient Assistance” program through the Gilead pharmaceutical company was available for 
many years (Gilead, 2020a). Moreover, the USPTF recently updated its PrEP recommendation to 
reflect patients’ cost-sharing to zero copayments for the insured individuals. This change 
mirrored the Affordable Care Act’s requirement that preventive medicine with USPTF’s “A” or 
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“B” rating must be covered for patients without any cost-sharing (Keith, 2019). While exploring 
the “purview paradox” among PCPs, researchers simultaneously uncovered themes such as lack 
of knowledge and comfort among non-HIV specialized health care providers (Blackstock et al., 
2016; Edelman et al., 2019; Hakre et al., 2016; Petroll et al., 2017; Wood et al., 2018b; Zhang et 
al., 2019). 
Needs Assessment 
The CDC’s HIV prevention efforts endorsed by the federal government supported 
expanding the access and uptake of PrEP, especially in the rural and suburban communities of 
the southern United States (US; CDC, 2019a). To collaborate in this national effort, frontline 
providers that are not HIV specialists had to become the new champions to improve PrEP uptake 
for those individuals at risk for HIV. Retail clinics, ideally positioned in communities, employed 
frontline providers that can commit to reducing new HIV infections. Numerous researchers have 
supported the need for non-HIV specialists to improve their knowledge of PrEP, comfort to 
screen for at-risk HIV candidates, and confidence to prescribe PrEP therapy (Edelman et al., 
2019; Henny et al., 2019a; Henny et al., 2019b; Wilson, 2020). 
To further evaluate the needs for this quality improvement project, it was essential to 
evaluate the strengths, weaknesses, opportunities, and threats related to the organization and the 
topic of PrEP educational needs. The strengths, weaknesses, opportunities, and threats (SWOT) 
associated with the current project were analyzed (see Appendix A). 
Internal Strengths and Weaknesses 
A needs assessment was conducted for a retail clinic organization located in the southern 
region of the US to assess the need for an education intervention. With its mission statement, 
“helping people on their path to better health,” the retail clinics of Northern Virginia and 
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Washington, DC are recognized for healthcare convenience and quality (Anonymous, 2020). The 
organization’s values of “innovation, collaboration, caring, integrity, and accountability” were 
embedded in the quality services delivered seven days a week by dedicated nurse practitioners 
(NP) throughout the two regions (R22 and R23) (Anonymous, 2020). A significant strength of 
the organization was that most NPs were professionally committed and engaged in continuous 
educational opportunities to advance their knowledge and expertise. 
Another strength was the organization highly valued the Doctor of Nursing Practice 
(DNP) degree and supported DNP projects. Many changes to the current workflow were a result 
of past DNP projects conducted within the organization. Moreover, the chief executive officer 
(CEO) was a DNP leader who practiced engaging leadership. 
The major advantage of the project was the retail clinic organization’s commitment to 
innovative services while adhering to evidence-based practice (EBP) guidelines. The retail 
clinics also offered a variety of services, from minor episodic illnesses to routine health 
screenings that include screenings for sexually transmitted infections (STI). Most recently, a 
“Health Hub” theme was launched to offer more in-depth chronic care management and “young 
adult health” services. The Health Hub concept includes phlebotomy services that are needed for 
the full array of STI screening visits. Patients could conveniently get their blood work done in 
one setting instead of having to get to laboratory facilities. Thus, the internal strengths of the 
retail clinics presented the fuel to drive a PrEP education intervention towards improving 
provider knowledge that may ultimately delineate delivery of quality care. 
The organization was well-structured with many layers of company oversight, which 
presented some challenges for a DNP student-led initiative. With its national branding well 
known to the public, the retail health clinic organization did not permit the use of any patient 
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data. This included de-identified, aggregate patient data, as well as heavily secured clinical 
practice guidelines. As a highly innovative organization, new updates were occurring every week 
that impacted the planned PrEP education intervention’s timeline. Another weakness was the 
busy clinic setting that restricted the solo practitioner from becoming adequately engaged with 
learning activities in between patient visits. Newly graduated NPs with less than one year of 
experience faced more challenges of being inundated with overwhelming learning activities. 
Finally, retail clinics were not affiliated with infectious disease specialists and did not have 
relationships with these specialists. NPs, however, had collaborative medical directors they 
consulted when they needed further medical advice and guideline support. Despite these 
obstacles, the senior practice managers (SPM) for the Northern Virginia and Washington, DC 
regions fully endorsed this student-led PrEP education intervention. 
External Opportunities 
The current HIV epidemic has captivated the attention of the Federal and State 
government. Released in 2019, the federal project “Ending the HIV Epidemic: A Plan for 
America,” was a blueprint for reducing new HIV infections by 75% in the next five years and 
over 90% for the next ten years (HIV.gov, 2019). This national movement has influenced more 
frontline healthcare providers to reflect on their knowledge regarding HIV infections, comfort in 
screening patients for PrEP, and confidence in prescribing PrEP. After losing its coveted patent, 
the generic version of Truvada became available last year (Fitzsimons, 2019). Equally important, 
the retail clinics were noted as “PrEP Providers” through the CDC’s (2020b) “PrEP Provider” 
database link. Despite this title, PrEP service was underutilized in light of the concerning STI 
infection rates for the region. With metropolitan DC’s alarming HIV incidence rate, retail clinics 
in this region were perfectly positioned to join the national efforts to reduce the transmission of 
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HIV. 
External Threats 
The Health Hub concept consists of chronic disease management and a broader scope of 
young adult health services. The individuals that are “at-risk” for HIV often encounter barriers 
such as medical stigma, medical mistrust and perceived payment barriers that prevent them from 
receiving STI preventive services. Many uninsured individuals will be challenged to seek PrEP 
therapy due to the ongoing need for clinic follow-ups. If the Health Hub transformation failed for 
any reason, NPs would not have the opportunity to provide young adult health needs and 
screenings. Thus, the PrEP education intervention’s long-term desired outcomes will not be 
notable if clinics were faced with conditions that limited patient visit volume or unprecedented 
clinic closures.  Despite these potential threats, the organization supported the current student-led 
PrEP training initiative as a pilot study for both Regions 22 and 23 that represent Washington 
DC and Northern Virginia. 
Problem Statement 
About 80% of HIV infections in 2016 were transmitted by individuals who were 
undiagnosed with HIV and not receiving HIV care (HIV.gov, 2019). Although more than one 
million Americans may potentially benefit from PrEP, fewer than 25% of them have been 
prescribed HIV prevention therapy (CDC, 2020c). As frontline providers, the retail health clinic 
nurse practitioners (NPs) must have knowledge to provide PrEP screening, appropriate 
treatment, and precise management for at-risk HIV individuals of the community. 
PICOT Question 
For retail health nurse practitioners, how does PrEP education/training affect providers’ 
knowledge about PrEP clinical practice, comfort with screening, and confidence prescribing 
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PrEP for “at-risk HIV” individuals after the intervention period? 
Aims and Objectives 
The following aims were pertinent for the PrEP Education Intervention: 
1) Evaluate NPs’ pre-intervention baseline composite scores and ratings on all constructs 
including clinical practice knowledge about PrEP, comfort identifying “at- risk HIV” 
patients, confidence with PrEP prescribing practices, and likeliness to prescribe PrEP in 
the next six months. 
2) Implement an online education module on PrEP clinical practice knowledge, screening 
for “at-risk HIV” candidates, and PrEP prescribing practices. 
3) Evaluate NPs’ post-intervention composite scores and ratings on all constructs. 
4) Evaluate differences between NPs’ pre- and post-intervention composite scores and 
ratings on all constructs. 
5) Thirty days after completion of the PrEP education, reevaluate NPs’ composite scores 
and ratings on all constructs and compare with pre and post intervention scores and 
ratings. 
Smart Goals 
These sound goals provided direction, motivation, and a clear focus for the project 
implementation. The following were “SMART” goals that were specific, measurable, achievable, 
realistic, and timely. 
1) Develop and implement an online PrEP education module by July 24, 2020. 
2) Obtain NP’s baseline and post-intervention composite scores (constructs of knowledge, 
comfort, confidence, and likeliness to prescribe PrEP in the next six months) by 
September 26, 2020. 
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3) Post-survey PrEP’s composite scores and ratings on all constructs (clinical practice 
knowledge, comfort identifying at-risk HIV patients, confidence prescribing PrEP, and 
likeliness to prescribe PrEP within the next six months) will be improved from their 
baseline pre-survey scores following the education intervention and by the closure date of 
the post-survey period of September 26, 2020. 
4) Composite scores and ratings on all constructs for knowledge, comfort, confidence, and 
likeliness to prescribe PrEP will be retained with less than 5% loss at the 30 days post-
intervention completion date of November 7, 2020. 
Review of Literature 
A comprehensive literature review unveiled gaps regarding lack of knowledge, comfort, 
and confidence with clinical PrEP practice among non-HIV specialist healthcare providers. 
Evidence pointed to the positive value of delivering an education intervention to improve non- 
HIV specialist healthcare providers’ knowledge related to these constructs. An evidence table 
summarizing the information related to each reviewed source is included as Appendix B. 
Construct Definitions 
 Although the term “knowledge” is relatively clear, construct descriptions like “comfort,” 
“confidence” and “willingness” need clarification. The phrase, “knowledge about PrEP” was 
also noted in the literature review as the “familiarity” or “awareness” about PrEP 
pharmacotherapy and/or its prescribing practice guidelines (Edelman et al., 2019; Petroll et al., 
2017; Wilson et al., 2020; Wood et al., 2018b; Zhang et al., 2019). Additionally, words such as 
comfort, confidence, and willingness were used in numerous research studies that were 
evaluating the suboptimal uptake of PrEP (Edelman et al., 2019; Petroll et al., 2017; Wilson et 
al., 2020). For this purpose, this quality improvement project focused on the definitions reflected 
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in the online English dictionary. First, “confidence” as a noun describes the “belief in oneself 
and abilities” (Dictionary.com, 2021a, para 2). Next, the word “comfort” as a verb is described 
as, “to soothe, console or to reassure” (Dictionary.com, 2021b, para 1) while the verb usage as 
“comfortable” is defined as the physical and mental state of contentment and being “at ease” 
(Dictionary.com, 2021c, para 2). Since the word “willingness” can suggest consent or readiness 
and the preference to decide on one’s actions, it is important not to conflate comfort and 
willingness to prescribe PrEP since these are different constructs (Dictionary.com, 2021d). 
Provider Knowledge of PrEP 
Edelman et al.’s (2019) survey revealed that 85% of 240 general internists surveyed 
believed that PrEP practice should be integrated within the primary care setting instead of 
making referrals to specialists. To accomplish the integration of PrEP into clinical practice, most 
of the providers believed in training all providers at the practice site (42%) or employing an 
onsite PrEP provider (43%). Most of the surveyed providers in favor of enhancing their PrEP 
knowledge were practitioners who performed direct patient care (Edelman et al., 2019). The 
concept of the knowledge gap among non-HIV specialist providers has been explored in 
numerous articles. The term “knowledge” was broadened to include awareness or familiarity 
about PrEP, as well as the clinical concepts that support the management of PrEP therapy. 
Wilson et al. (2020) examined the poor uptake of PrEP for the US Navy despite Truvada’s 
availability at no cost. Out of the 432 Navy providers participating in the survey, most rated their 
knowledge as “poor” (41%) or “sufficient” (31%), compared to 17.1% who rated their 
knowledge as “good” or “excellent” (6.9%) (Wilson et al., 2020). Among providers that self- 
identified as being knowledgeable about PrEP, 29% were found to prescribe PrEP more often 
compared to those providers with poor knowledge ratings (6%) (Wilson et al., 2020). It is not 
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surprising that only 19% of Navy providers reported ever prescribing PrEP (Wilson et al., 2020). 
Similarly, Henny et al. (2019b) conducted the “K-Bap Study” that explored HIV-related 
knowledge, behaviors, attitudes, and practices among providers in the southeast part of the 
country. The online survey of 820 PCPs revealed that more than 52% of the providers lacked 
familiarity with PrEP (2019b). Arising from the potential side effect profile, insufficient PrEP 
knowledge can predict hesitancy to prescribe even to eligible patients meeting the screening 
criteria. A recent meta-analysis conducted by Zhang et al. (2019) examined healthcare 
professionals’ obstacles that blocked the optimal PrEP implementation. Aside from PrEP’s cost, 
safety, and side effect that were identified as barriers, providers’ lack of awareness, knowledge, 
skills, and lack of training were found to impact PrEP provision among healthcare professionals 
(Zhang et al., 2019). The pooled proportion of PCP with awareness of PrEP was 68% (95% CI 
55-80%), and the rate of prescribing PrEP was 24% (95% CI=17-32%) (Zhang et al., 2019). 
These studies revealed the knowledge gap that exists among frontline PCPs and other healthcare 
professionals regarding PrEP prescribing practices. 
Several studies revealed providers’ lack of knowledge as a barrier to prescribing PrEP. 
Clement et al. (2018) found that 60% of the Duke Health System’s PCPs, before the in-person 
education intervention, answered “lack of knowledge” as the reason for not having prescribed 
PrEP. Similarly, Irungu et al. (2019) found a lack of knowledge of ART and PrEP eligibility, 
indications, benefits, and side effects among Kenyan healthcare workers. Researchers found 
improved knowledge and confidence after presenting the two-day interactive training called, 
 “Partners Scale-Up Project” for the public health facilities in Kenya (Irungu et al., 2019). The 
pre intervention’s mean score of 61.7% suggested a lack of knowledge among various healthcare 
workers (Irungu et al., 2019). Moreover, Newman et al. (2018) conducted an educational 
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intervention for medical residents and found that 22% of the 45 residents surveyed were not at all 
familiar with PrEP before the education session. 
Comfort with Screening for PrEP Eligibility 
Providers’ prescribing practices depend on knowledge of the drug and understanding the 
patients’ ultimate benefit from pharmacotherapy options. Specifically, providers need to assess 
the PrEP eligibility with patients through the sensitive discussion of patients’ sexual practices. 
Few studies have used the term “comfort” to address providers’ attitudes about being engaged 
with PrEP practice and sensitive patient discussions (Clement et al., 2018; Irungu et al., 2019; 
Newman et al., 2019; Wilson et al., 2020). Newman et al. (2019) found that providers’ comfort 
in assessing clinical eligibility across different clinical situations did not improve after their PrEP 
training session. Pre- and post-training results for comfort with assessing clinical PrEP 
eligibility, which included sexual risk categories, were not statistically significant. However, 
“comfort” with prescribing PrEP increased among the medical students, who had a pre- 
intervention score of 35% compared with the post-intervention score of 70% (p = .015) 
(Newman et al., 2019). Irungu et al. (2019) found that 30% of providers initially reported feeling 
“very uncomfortable” and “unsure” before the PrEP training for serodiscordant couples of 
Kenya. Likewise, Clement al. (2018) found 42% of PCPs, that had never prescribed Truvada, 
indicated “lack of comfort” as the reason for not ever prescribing PrEP. Not surprisingly, Wilson 
et al. (2020) found that Navy providers who were most comfortable assessing patients’ sexual 
risk behaviors had increased knowledge about PrEP. Although these studies collectively 
 suggested an unclear relationship between knowledge of PrEP, comfort in assessing patient risk 
behaviors, and PrEP prescribing practices, the results suggested that training improved 
providers’ comfort with screening for “at-risk HIV” behaviors and prescribing PrEP. 
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Confidence with Prescribing PrEP 
With an unclear picture of how knowledge influenced likeliness to prescribe PrEP and 
the role of comfort in assessing patient risk behaviors, it was worth exploring how education may 
improve provider confidence managing and prescribing PrEP therapy. The confidence to 
prescribe Truvada and manage patients on PrEP therapy stemmed from providers’ PrEP 
knowledge and prior experience (Mayer et al., 2018). Several studies revealed that providers 
were not initially confident with Truvada’s safety, effectiveness, and prescribing practices due to 
lack of awareness of the clinical PrEP guideline (Henny et al., 2019a; Newman et al., 2019; 
Wilson et al., 2020). For this purpose, numerous studies and PrEP experts emphasized the need 
for frontline providers to participate in PrEP educational or training sessions (Clement et al., 
2018; Henny et al., 2019b; Wilson et al., 2020; Wood et al., 2018b; Zhang et al., 2019). Based on 
the research, it was important to establish whether educating healthcare providers about PrEP 
improved knowledge in prescribing PrEP therapy. 
In short, many studies explored the provider barriers that can be addressed through 
increased education. The literature review uncovered a variety of PrEP related education 
interventions ranging from 20–60-minute presentation to weeks of ongoing support. In fact, 
Henny et al.’s (2019b) study highlighted the correlation between HIV-related training and 
familiarity with PrEP practice which in turn increased prescribing of PrEP. Focused provider 
training on PrEP implementation may improve knowledge, comfort, and confidence to improve 
their likeliness to prescribe PrEP therapy (Zhang et al., 2019). 
 Education to Improve PrEP Prescribing 
Five recent quasi-experimental studies were systematically reviewed and assessed for 
evidence and quality. These studies evaluated whether educational interventions improved 
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provider knowledge, comfort assessing patient risk, confidence with PrEP therapy management, 
and the likelihood of providers to prescribe this pre-exposure antiretroviral therapy. Most studies 
resulted in notable improvements in PrEP knowledge following educational intervention(s) 
(Clement et al., 2018; Irungu et al., 2019; Newman et al., 2019; Sales et al., 2019; Wood et al., 
2018b). 
Wood et al. (2018b) found that incorporating PrEP telementoring support into an existing 
HIV project was feasible and beneficial for providers. More than 93% of the surveyed providers 
reported that knowledge topics for PrEP practice, such as pharmacologic side effects, candidacy, 
and adherence issues, were covered “extremely” or “moderately” well (Wood et al., 2018b). As a 
secondary analysis, Sales et al. (2019) found that 28 providers and staff from family planning 
clinics gained higher PrEP knowledge after a 1.5-hour training session (with a pre mean value of 
3.26 and post-mean-value of 5.13, p<.001). Newman et al. (2019) also found increased 
knowledge among medical residents who participated in a PrEP education intervention, with the 
average posttest knowledge score of 92% compared to the pretest score of 66%. Likewise, 
Irungu et al. (2019) demonstrated an improvement of knowledge after a two-day training 
intervention with a significant gain in the posttest mean score (62% on pretest versus 86.4% on 
posttest). 
In addition to knowledge improvement, Irungu et al. (2019) found that providers gained 
“comfort” treating HIV serodiscordant couples after the educational intervention (22.8% to 
67.3%, p<.001). Besides the quantitative approach used to measure an increase in comfort 
 following an educational intervention, Irungu qualitatively measured the providers’ experience 
with the intervention and found that many participants reported “improved confidence” during 
post-intervention interviews. Similarly, in addition to improving PrEP knowledge, Sales et al. 
THE PREP EDUCATION INTERVENTION                 21 
(2019) found providers were more comfortable in their ability to identify appropriate candidates 
for daily Truvada therapy. The increase in knowledge, comfort, and confidence found in the 
literature also seemed to influence providers’ likeliness to prescribe PrEP. For instance, Newman 
et al. (2019) noted an hour-long education intervention improved the subjects’ likeliness to 
prescribe PrEP within the next six months from 32% (pretest) to 67% (posttest). Finally, Clement 
et al. (2018) demonstrated that after an educational intervention, providers prescribed PrEP to 
35% of eligible patients, as compared to only 17% of patients before the intervention (with a 
statistical significance of < .01). Overall, the literature revealed that educational/training 
interventions can improve provider knowledge, comfort in assessing for PrEP candidacy, 
confidence in PrEP therapy, and likeliness to prescribe PrEP in the future.  
Knowledge Gap 
Education interventions, varying from one hour to two days in duration, were noted to 
reveal improved knowledge for a variety of providers. Specifically, the knowledge gap amongst 
the PCPs of the southeast region identified through the “K-Bap” survey underscored the need to 
strengthen HIV-related knowledge and practice guidelines for physicians, NPs and physician 
assistants (Henny et al. 2019b). This was especially alarming since the highest burden of HIV 
prevalence existed in the southern part of the nation. Numerous research findings consistently 
supported various forms of HIV-related training to improve the sluggish uptake of PrEP for those 
“at-risk” for HIV transmission. 
Evidence-Based Practice Translation Model 
  Developed by the Iowa Model Collaborative group, the Iowa Model Revised: Evidence- 
Based Practice to Promote Excellence in Health Care Process (IMR) was applied to guide the 
PrEP Education Intervention. The path to solving the clinical problem included decision markers 
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with evaluation stages that acted as feedback loops with appropriate recommendations during the 
practice change implementation process (Buckwalter et al., 2017). The IMR’s essential phases 
were as follows: identifying triggering issues, forming the interprofessional team, reviewing the 
evidence, accomplishing critique and synthesis of the evidence, piloting the implementation, 
integration of practice changes, and dissemination of outcomes (Iowa Model Collaborative, 
2017). 
Application of the Iowa Model Revised: Trigger Identification 
The nation’s capital, Washington, DC has one of the highest HIV incidence rates in the 
country. Individuals qualifying to receive PrEP therapy are likely to visit retail health clinics for 
minor episodic illnesses or routine screening needs. NPs’ knowledge gap pertaining to PrEP was 
identified as a reason to conduct this project. Regardless of the NPs’ inadequate PrEP clinical 
knowledge or experience, the retail clinics were already identified as “PrEP Providers” for the 
Washington DC metropolitan region (CDC, 2020b). Namely, PrEP encounters included 
screening those at high risk for HIV, as well as prescribing the daily therapy available on the 
market today. As an innovative organization, the retail health clinic organization approved the 
EBP initiative that was directed at improving PrEP knowledge, comfort, and prescribing 
practices for the NP providers. The Iowa Model Revised (IMR), depicted in a concise flow 
diagram (Appendix C), was used to describe the step-by-step process in implementing the PrEP 
education initiative. 
Application of the Iowa Model Revised Overview 
1) Established a problem-focused trigger that created the PICOT statement. 
2) Formed a team from the stakeholder group (Table 1). 
3) Performed a literature review and synthesis and established the urgency for PrEP 
THE PREP EDUCATION INTERVENTION                 23 
education interventions. 
4) Designed and developed an online, evidence-based PrEP education tutorial and utilized 
an evidence-based tool. 
5) Implemented the Pilot PrEP Education Intervention for Regions 22 and 23. 
6) Evaluated the Pilot Intervention’s pre and post surveys for improved survey scores. 
7) Administered post-intervention 30-day retention survey. 
8) Reevaluated survey results that include the 30-day retention survey scores. 
9) Raffled away gift cards for those that completed all three phases of the survey. 
10) Disseminated outcomes with results to the organization. 
Application of the IMR: Practice Integration and Dissemination of Outcomes 
After completion of the 30-day retention survey, the goal was to record and disseminate 
the quality improvement project outcomes throughout the organization’s two regions. The 
success of the intervention was shared with the regional quality representatives. The PrEP 
Education Intervention did receive approval to be posted in the organization’s intranet site to 
encourage completion of this learning opportunity for all providers in the organization. 
Methodology 
Research Design 
The PrEP Education Intervention was an online quality improvement project that aimed 
to improve provider knowledge, comfort and confidence regarding screening for patients that are 
at-risk for human immunodeficiency virus (HIV) and prescribing PrEP. The project evaluated 
providers’ knowledge of PrEP clinical practice, comfort in screening “at-risk HIV” patients, and 
confidence in prescribing PrEP before and after an online educational tutorial. The online 
delivery of the educational intervention allowed busy practicing providers to obtain the needed 
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education on-demand, rather than trying to coordinate an in-person didactic session suitable for 
their schedules. The design of the study was a pre and post-test design in which participants first 
received a survey of their baseline PrEP clinical practice knowledge, comfort in screening for 
PrEP candidacy, and confidence in prescribing PrEP for “at-risk HIV” individuals (Price et al., 
2015). Following the online educational intervention, the participants received a survey 
immediately post-training to measure their learning, comfort, and confidence related to clinical 
PrEP practice. It was essential to ensure that improvements in prescriber knowledge, comfort, 
and confidence were retained over time. After 30 days, participants received a follow-up survey 
to measure long-term knowledge retention, comfort, and confidence in PrEP clinical practice and 
prescribing. The surveys also measured the providers’ likeliness to prescribe PrEP in the next 
six-month period. 
Sampling Strategy 
The target population for this initiative was health care providers (i.e., nurse 
practitioners) who were employed for a large retail health clinic organization throughout 
Northern Virginia (NoVA) and Washington DC. All eligible participants were contacted during 
recruitment. The sample, therefore, represented a convenience sample of family practice NPs in 
the target region. 
Inclusion/Exclusion Criteria 
All clinical nurse practitioners, who were full time, part-time, and committed casual part- 
time staff for the two regions, were eligible to participate in the learning session. Any NP with 
anticipated departure from the organization within three weeks of the survey launch date was 
excluded from participation. 
THE PREP EDUCATION INTERVENTION                 25 
Setting and Study Considerations 
All parts of the survey were delivered in a remote fashion. The study included online 
surveys and an online educational tutorial that were sent via emails. Participation took place 
during providers’ “down time” or during break times. Participants were able to complete the 
session anywhere they had internet and computer access and were able to pause and resume the 
tutorial at any time. The organization’s official support was received from the DNP Project 
Committee on July 3rd, 2020. 
This project received an approval from the Institutional Review Board of the George 
Washington University Ethics Committee on July 15th, 2020 (see Appendix E). As a QI project, 
there was no risk of harm to the subjects participating in the PrEP educational activity. All 
demographic information and survey responses were kept confidential and only available for the 
study’s investigators until the end of December 2023. 
Recruitment Strategy 
Participant recruitment was elicited through emails. Also, senior practice managers 
(SPM) for the two regions, through the daily morning huddles, encouraged their regions’ NPs to 
participate. Pre-intervention emails (Email #1) were sent to participants on multiple dates one 
week before the project launch date to explain and recruit participation for the upcoming study. 
This first email before the project launch date was directed at increasing awareness of the 
upcoming educational session. The e-mail contained the project syllabus and was sent to all NPs’ 
work email at least two times during the first week. The syllabus included the learning 
objectives, length of training, the purpose of the education session, and appropriate contact 
information (See Appendix F). At the initiation of the project launch phase, participants were 
sent the “Pre-survey” emails (Email #2) to participate in the study with a web link to complete 
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the pre-survey. The pre-survey was launched during weeks two and three. This email included 
the link for the pre-survey and was sent at least two times weekly to ensure that NPs were able to 
access the weblink in a timely fashion despite job demands. During weeks four through six, 
“Education Intervention” emails (Email #3) containing the pre-survey, PrEP tutorial link and the 
post-survey were sent to invite participants to complete the intervention training. In an attempt to 
recruit additional participants, “Education Intervention” emails were sent out three times during 
week nine. This email presented a link that allowed the participants to advance to the 
intervention only if they had already completed a presurvey. Four weeks after the closure of the 
education training, the final “retention survey” emails (Email #4) were sent during weeks 
fourteen and fifteen. As an added incentive, five $20 Target gift certificates were raffled off for 
participants who completed the entire PrEP Education Initiative, including the pre- and post- 
survey, and 30-day retention survey. An overview of the completed recruitment strategy and data 
collection sequence can be found in the figure methodology map (Figure 2). 
Sample Size 
There were approximately 110 NPs that covered more than 42 retail clinics for the two 
regions across Northern Virginia and Washington, DC. The appropriate sample size needed for 
this study was determined by estimating the effect size necessary for adequate power using 
Cohen’s d sample size conversion. A sample size of 27 was needed for a “moderate” effect size 
of .50 and a power of 0.80 in order to conduct a repeated-measures ANOVA with a significance 
level of 0.05 (Sullivan & Feinn, 2012). For possible sample size attrition factors, an additional 
15% was considered for a total sample size of 31. 
 PrEP Education Intervention 
The link to the education intervention included an “intro video” that introduced pertinent 
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background information about the current HIV epidemic and the nation’s mission to improve 
PrEP uptake. The six-minute video was an optional background prelude to the PrEP tutorial. 
The PrEP for HIV Prevention e-learning tutorial was developed from the CDC’s latest clinical 
guidelines on pre-exposure prophylaxis, identifying indications for PrEP, and the current 
evidence-based practice and PrEP therapy management. The five topics were as follows: “About 
PrEP,” “PrEP Candidacy,” “PrEP Eligibility,” “PrEP Prescriptions,” and “Practice Scenarios.” 
The e-learning tutorial was designed to be engaging and interactive that allowed feedback for the 
chosen answers.  The case scenarios promoted self-directed e-learning through making decisions 
based on the case presentations (Moore, 2021).  The latest FDA-approved PrEP agent, Descovy, 
was also included to educate NPs on all pharmacologic agents available on the market (Gilead, 
2020b). Upon completing the tutorial, participants were directed to complete the post-survey. 
Project Timeline 
The total duration of the PrEP Education Intervention was sixteen weeks long. Table 2 
lists detailed weekly activities of the QI project. While waiting for the organizational approval, 
the Principal Student Investigator (PSI) developed the online PrEP educational tutorial. The final 
consent to launch this DNP project from the Retail Health Clinic’s DNP Project Committee was 
received on July 3rd, 2019. Next, the DNP Project Proposal received approval from the George 
Washington Institutional Review Board Committee on July 15, 2019. Shortly after receiving the 
approvals, preparation was made to launch the project with support from the two regions’ senior 
practice managers (SPM). On July 27th, the project started with one week of “pre-intervention” 
emails that described the intent of the study. For the next several weeks, emails were sent 
routinely to elicit interest and participation. The study ended with the closure of the retention 
survey and list of the ten raffle winners. 
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Survey Instrument 
The PrEP Education Intervention included a survey instrument that was delivered in three 
phases: pre-survey, post-survey and retention survey. This survey tool was compiled from a 
combination of validated, previously used, and tested survey questions that were developed by 
expert researchers. A total of 21 items were taken from an existing survey instrument called PCP 
PrEP Survey that had been refined and piloted from an already existing Integrated 
Buprenorphine and HIV Care Evaluation (BHIVES) survey (Blackstock et al., 2016; Edelman et 
al., 2019; Edelman et al., 2017). 
The original 57-item survey that was pilot-tested in an iterative manner by the authors 
was used as an online survey to the members of the Society of General Internal Medicine 
(SGIM). The PCP PrEP Survey conducted for this national professional organization’s academic 
general internists contained provider sociodemographic, practice characteristics, self-rated 
knowledge, attitudes, and beliefs about PrEP and PrEP practice adoption (Blackstock et al., 
2016). Consent was obtained to adapt the PCP PrEP Survey items from the principal investigator 
on March 28, 2020. Furthermore, Blumenthal et al.’s (2015) five-question PrEP Knowledge 
Survey that was modified from the Fenway Institute’s previously utilized instrument was 
reviewed. Blumenthal et al. (2015) did mention its weak internal consistency (alpha score of 
0.22) due to having only five questions and containing specific questions about various past 
clinical trials. Due to the current research advancements with PrEP, only two of the knowledge- 
based questions from Blumenthal et al. (2015) applied to the current PrEP survey. Upon 
requesting the use of this survey instrument, an email with the investigator’s permission was 
received on April 3, 2020. Additionally, five questions were developed from the 2017 CDC’s 
PrEP Clinical Guideline and recently updated CDC’s PrEP website (CDC, 2019d). 
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Consent and Survey Content 
A simple information sheet explaining the project and consent process was attached to 
every email and available for all prospective participants (Appendix I).  Advancing to the pre- 
survey link was synonymous with consent to participate in the study.  This project’s survey tool 
contained a total of 23 survey items that were compiled from the existing survey instruments and 
five items from the CDC’s PrEP clinical practice guideline (see Appendix J). Along with the 
necessary items pertaining to demographics and prior experiences, the survey tool presented with 
23 questions about the constructs of PrEP clinical practice knowledge, comfort, and confidence 
as well as providers’ likeliness to prescribe PrEP in the next six months. 
Demographics and Past Experience 
The survey instrument started with basic demographic questions that included the 
subjects’ prior experiences. The five demographic questions pertained to the following: age, 
years of experience as NP; race/ethnicity; education level; and gender. The next five questions, 
related to the subjects’ prior experience with PrEP, earned categorical responses of “yes” or “no” 
as well as one 5-point Likert scale that expressed the NPs prior knowledge. These five questions 
were intended to understand the subjects’ previous experience and one self-rated item about 
PrEP’s potential side effects. 
The “Knowledge” Construct 
The knowledge questions were designed to test the basic PrEP clinical practice that had 
been standardized through the CDC’s PrEP clinical guideline. There were three multiple-choice 
items included in the survey adopted from the existing PCP PrEP Survey with Likert-type 
choices to measure the providers’ perception based on her/his knowledge of the effectiveness 
and safety of PrEP. The 4-point Likert Scale consisted of 1= “not at all,” 2 = “slightly,” 3 = 
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moderately,” and 4 = “extremely.” Only two items with multiple choice answers from 
Blumenthal’s PrEP Survey were used. Five questions with multiple choice answers were 
developed from the CDC’s clinical practice guideline. Knowledge related to these items was 
explained and reinforced in the online PrEP tutorial. All items received “1-point” for the correct 
answer for the maximum cumulative value of 10 points. An increased knowledge score between 
baseline (pre-survey) and post-intervention demonstrated improvement in knowledge. This 
section was intended to measure the pertinent knowledge regarding PrEP’s clinical practice 
endorsed by the CDC clinical guideline and its continuously updated website. 
The “Comfort” Construct 
While knowledge about clinical PrEP practice was an essential component, assessing 
provider comfort to screen the clinical eligibility for daily PrEP was also important. Thus, the 
PrEP Education project evaluated if the education intervention improved providers’ comfort in 
identifying patients with “at-risk” HIV behaviors that were eligible for PrEP therapy by 
comparing changes in pre- and post-intervention comfort ratings. Data for the comfort construct 
was collected using the pre-, post- and follow-up surveys distributed to the providers. The choice 
of answers was presented in a 4- point Likert Scale to accurately assess provider comfort levels 
before and after the educational intervention. A maximum of 16 points for comfort-related 
answers represented the provider’s comfort level as “extremely comfortable” in identifying the 
various high “at-risk HIV” individuals. At the same time, a total of four points indicated “not at 
all comfortable” at identifying “at-risk HIV” individuals for the various risk behavior categories. 
Specifically, the 4-point Likert scale descriptions were as follows: 1 = “not at all comfortable”; 2 
= “slightly comfortable”; 3 =” moderately comfortable”; 4 =” extremely comfortable.” 
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The “Confidence” Construct 
The self-confidence concept was a cumulative notion of “believing in oneself” and 
certainty that occurs with knowledge and experience (Dictionary.com, 2021a, para 2). Thus, the 
working definition for the confidence construct was the confidence to prescribe PrEP that can be 
attained with learned knowledge of the current clinical practice guideline that included the safety 
profile, side effects, and lab monitoring essentials related to the antiretroviral treatment. The 
original PCP PrEP Survey’s questions used the word “willingness” to prescribe PrEP, and these 
questions were modified to say, “confidence” to prescribe. When Blackstock et al. (2016) 
surveyed the academic general internists in 2015, the adoption of PrEP practice among PCPs was 
a relatively novel idea. The authors used the terms “comfort and willingness” to ascertain PCPs’ 
attitudes and beliefs associated with PrEP practice adoption (Blackstock et al., 2016).  
Historically, “willingness to prescribe” was measured when PrEP was a new therapy with limited 
guidance for non-HIV prescribing providers. Current evidence-based guidelines recommend 
PrEP as a standard of care, so it was more appropriate to assess “confidence” instead of 
“willingness” to prescribe. 
This QI project evaluated if the education intervention improved providers’ confidence in 
prescribing PrEP by comparing providers’ pre- and post-intervention confidence ratings. Data for 
the confidence construct were collected using the pre-, post- and 30-day follow-up surveys 
distributed to the retail clinic providers. A 4-point Likert scale was used to assess the level of 
providers’ confidence to prescribe PrEP based on information known about patients’ sexual 
behaviors and drug use. In other words, the eight questions explored the NP providers’ self-rated 
ability to identify those “at-risk HIV” patients that would benefit from the daily PrEP therapy as 
well as having the confidence about PrEP’s pharmacology profile. A maximum of 32 points 
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indicated “extremely confident” rating versus eight points that revealed “not at all confident” 
with PrEP prescribing patterns and clinical practice. The confidence to prescribe PrEP for the 
“at-risk HIV” patients symbolized NPs’ confidence with the overall management and prescribing 
of PrEP therapy. Provider confidence scores were measured as a total composite score. 
Likeliness to Prescribe PrEP in Six Months 
This QI project evaluated if the education intervention improved the providers’ likeliness 
to prescribe PrEP by comparing baseline and post-intervention likeliness to prescribe PrEP. Data 
for likeliness to prescribe PrEP were collected using the pre-, post- and follow-up surveys 
distributed to the retail clinic providers. The providers’ likeliness to prescribe in the next six 
months were measured by one question on a 4-point Likert scale. Hence, this question revealed 
whether the intervention did pose an impact on the providers’ likeliness to prescribe. The 
participant responses were analyzed to determine the participants’ likeliness to prescribe PrEP 
after completing the online PrEP tutorial. 
Primary Data Analysis 
The anticipated outcomes were evaluated by measuring the constructs of PrEP clinical 
knowledge, comfort, confidence and likeliness to prescribe. The project’s variable table was 
created to evaluate retail NPs’ survey scores throughout the three survey phases (see Appendix 
K). A paired t-Test and repeated measures ANOVA were conducted to determine differences in 
pre, post, and 30-day post PrEP tutorial intervention. Thus, the outcomes being measured were 
the composite scores for pre- to post-surveys and for pre, post and retention surveys. Also, the 
final knowledge score was examined to assess the level of retention loss following 30 days after 
the post-survey period. The outcomes measured for this aim, as the essence of this project, were 
to compare the constructs’ composite scores to highlight if changes had occurred after delivery 
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of the education intervention. Furthermore, the retention survey was an evaluation of NPs’ 
likelihood of retaining the benefit of the education intervention already received more than 30 
days ago. 
Description of the Software 
All the surveys and the education tutorial were accessed through Survey Monkey links 
that were delivered through the organization’s emails. Survey data were collected using the 
Survey Monkey platform. A data dictionary was created to organize the collection of the survey 
data (Appendix L). After the survey collection period, data was downloaded and stored in Excel 
spreadsheets. By using the Excel spreadsheet, data were “cleaned” to remove all incomplete 
surveys and organized according to the data dictionary. Data were organized with appropriate 
data codes, and each constructs’ total scores were obtained using Excel’s mathematical formulas. 
After organizing all valid data, the Excel spreadsheet’s working datasheet was exported to 
Statistical Package for the Social Sciences (SPSS). The SPSS version used for data analysis was 
SPSS version 27. SPSS was used to analyze the data to generate descriptive statistics for the 
analysis of means, percentages and standard deviations. The statistical tests chosen for this 
project were the paired t-Test, one-way repeated measure ANOVA, and Friedman’s Rank 
ANOVA. 
Needed Resources 
Resources required for the PrEP Education Intervention included time, dedication, and 
effort into developing the intervention and the overall project for the student investigator. The 
budget for implementing this project was minimal. As shown in the project’s budget table, the 
total monetary budget for this project was less than $1,000 (see Appendix M). Aside from the 
learners’ engagement time and effort, this education intervention did not need any organizational 
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A total of 39 nurse practitioners participated in the pre- and post-surveys and completed 
the online educational tutorial. Participants’ ages ranged from 28 to 56 years with a mean age of 
39.0 years (SD = 8.89). On average, they had over six years of nurse practitioner experience (M 
= 6.35, SD = 8.98). Thirty-eight were females and one was male. Twenty-nine percent of the 
participants identified their race/ethnicity as African American or Black, 24% identified as 
Asian, 3% identified as Hispanic or Latino, 37% identified as White/ Non-Hispanic, and 8% 
selected “Other.” Eighty-seven percent of the participants were employed full-time, whereas 3% 
were employed regular part-time, 8% were casual employees or committed part-time, and 3% 
selected “Other.” For education status, 76% of nurse practitioners held an MSN or master’s 
degree and 24% held a DNP/Doctorate (see Table 4). 
Participants were asked about their prior experience with PrEP (see Table 5). Although 
over 97% of participants had heard about PrEP, less than 50% of participants had ever initiated a 
conversation about PrEP with a patient. More than 65% of participants indicated that they did 
have patients ask about PrEP, but almost half of the participants had never had any experience 
prescribing PrEP. Additionally, when participants were asked about their prior knowledge of the 
potential side effects of PrEP’s, less than 50% rated their knowledge as “Good” or “Very Good.” 
Data accuracy was achieved by rechecking survey data against an Excel spreadsheet by 
two members of the project group. The refined Excel data was exported to SPSS 27 which was 
used for the statistical analysis. There was one survey with a missing composite score for the 
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comfort construct. This did not significantly impact the results of the analysis. 
Pre- vs. Post-Survey Scores 
A paired t-Test was performed to assess differences in the 39 participants’ pre and post 
intervention knowledge of PrEP clinical practice, comfort screening at-risk HIV individuals, and 
confidence in prescribing PrEP (see Table 6). Analyses revealed a significant difference (t (38) = 
5.16, p < 0.001) between the pre-survey scores (M = 6.44, SD = 1.37) and post-survey scores (M 
= 8.10, SD = 1.65) for knowledge of PrEP clinical practice. There was a significant difference in 
the pre-survey scores (M = 9.97, SD = 3.41) and post-survey scores (M = 11.74, SD=3.14) for 
comfort screening at-risk HIV individuals; t (37) =2.67, p <.008. Confidence in prescribing PrEP 
was significantly different based on the pre-survey (M = 19.54, SD = 6.79) and post-survey 
scores (M = 24.18, SD = 5.70); t (38) = 4.29, p < .001). Overall, the online tutorial intervention 
had a significant effect on all three constructs: knowledge, comfort, and confidence. 
Post- and Retention Surveys 
Three one-way repeated measures ANOVA within-subjects analysis was performed to 
assess the effects of the PrEP education intervention on knowledge of PrEP clinical practice, 
comfort screening at-risk HIV individuals, and confidence in prescribing PrEP for the 31 
participants who completed the pre-, post-, and retention surveys.  Figure 3 presents the mean 
scores for the three survey phases in a diagram. Likewise, the mean scores and descriptive data 
for the repeated measures of knowledge of PrEP clinical practice are depicted in Table 7. There 
was a significant main effect of the PrEP education intervention on providers’ knowledge of 
PrEP clinical practice (F (2, 60) = 13.83, p < .001, η p 2 = 0.315). Post hoc tests for pairwise 
comparisons using the Bonferroni correction revealed that participants’ knowledge of PrEP 
clinical practice increased significantly between the pre-survey (M = 6.23; SD = 1.36) and post-
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survey (M = 8.13; SD = 1.65; p < .001). Participants’ knowledge of PrEP clinical practice also 
increased significantly between the pre-survey (M = 6.23; SD = 1.36) and retention phase (M = 
7.19; SD = 1.78; p = .020). Participants’ knowledge of PrEP clinical practice post-survey scores 
and retention scores were not significantly different (see Table 8). 
Figure 4 depicts mean scores for the comfort construct measured at 95% confidence 
interval that was obtained from the three survey phases. Specifically, this construct assessed 
whether the PrEP education intervention affected providers’ comfort screening “at-risk HIV” 
individuals. Table 9 presents the mean scores with the standard deviation for the 30 participants. 
There was a significant main effect of the PrEP education intervention on the participants’ 
comfort screening at-risk HIV individuals (F (2, 58) = 8.26, p = .001, ηp2 = 0.222). Post hoc tests 
for the pairwise comparisons using the Bonferroni correction revealed that participants’ comfort 
screening “at-risk HIV” individuals increased significantly between the pre-survey (M = 10.0; 
SD = 3.57) and retention phase (M = 12.50; SD = 3.38; p = .001). Participants’ comfort 
screening “at-risk HIV” individuals pre-survey scores (M = 10.0; SD = 3.57) were not 
significantly different from the post-survey scores (M = 11.67; SD = 10.41; p = .08) and their 
post-survey scores and retention scores were not significantly different. Table 10 presents the 
comfort construct findings that were notable in the repeated measures ANOVA analysis (see 
Appendix S).  
Figure 5 represents mean scores for the confidence construct measured at the 95% 
confidence interval that was obtained from the three survey phases. The mean and the standard 
deviation for the 31 participants is shown in Table 11. As notable in Table 12, there was a 
significant main effect of the PrEP education intervention on confidence in prescribing PrEP 
(F (2, 60) = 21.50, p < .001, ηp2 = 0.413). Post hoc tests for the pairwise comparisons using the 
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Bonferroni correction revealed that participants significantly increased their confidence in 
prescribing PrEP from the pre-survey scores (M = 19.65; SD = 7.00) compared to the post- 
survey scores (M = 24.90; SD = 5.47; p < .001). Participants significantly increased confidence 
in prescribing PrEP from the pre-survey scores (M = 19.65; SD = 7.00) compared to the 
retention surveys (M = 25.48; SD = 4.12; p < .001). Participants’ confidence in prescribing PrEP 
post-survey scores and retention scores were not significantly different (p > .999). As shown in 
Appendix V’s table, the improved confidence to prescribe PrEP following the intervention can 
be noted through the repeated measures ANOVA analysis.  Figure 6 is a bar graph which depicts 
the mean scores across all phases of the survey for the knowledge, comfort and confidence 
constructs. Across all constructs, retention scores    differed from pre-survey scores, but did not 
differ from post-survey scores. 
Likeliness to Prescribe PrEP 
A Friedman’s rank ANOVA test was performed on data collected from the 31 
participants who completed the pre-, post-, and retention survey to assess one ordinal item 
regarding likeliness to prescribe PrEP in the next six months. Figure 7 displays the mean 
rankings for the pre-, post- and retention surveys. The results indicated that rankings for 
likeliness to prescribe were rated significantly different in the three groups (χ2(2) = 22.45, p < 
.001). The Post hoc tests for the pairwise comparisons using the Bonferroni correction revealed 
that participants’ likeliness to prescribe PrEP increased significantly from the pre-survey’s mean 
ranking of 1.52 compared to the post-survey’s mean ranking of 2.17 with p = .04. Participants’ 
ratings of likeliness to prescribe PrEP significantly increased from the pre-survey’s mean ranking 
of 1.52 compared to the retention survey’s mean ranking of 2.32 with p =.01. Participant’s 
likeliness to prescribe PrEP for the post-survey and retention survey were not significantly 
different (see Table 13). 
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Discussion 
Many researchers have studied various forms of education and training to promote PrEP 
as an HIV prevention strategy. Specifically, there were many studies focused on targeted 
education for the frontline primary care providers. The current QI project was aimed at 
enhancing retail NPs' ability to perform PrEP related encounters, especially with the “at-risk 
HIV” patients. Indeed, the project’s online PrEP tutorial was effective in improving knowledge 
of PrEP clinical practice, comfort screening “at-risk HIV” patients, confidence in prescribing 
PrEP, and the likeliness to prescribe PrEP in the next six months for retail health clinic providers. 
Pre-survey revealed demographic characteristics as well as valuable baseline scores. The 
diverse group of NPs was mostly females with over six years of advanced nursing practice 
experience. The average age of participants was 39 years. This “mature” age suggests that the 
practitioners had additional various clinical nursing experiences. While almost everyone had 
heard about PrEP, more than half of the NPs had ever initiated a conversation about PrEP with a 
patient. Survey results suggested that only about half of the participants had ever prescribed 
PrEP before. Less than 10% had “excellent” or “very good” knowledge about PrEP’s potential 
side effects. Despite the NPs’ veteran status, the participants lacked knowledge about PrEP’s 
prescribing practices. In addition to the participant characteristics, baseline scores for all 
constructs were obtained through the pre-survey. 
Post-survey scores were evaluated against baseline scores to note the effects of the 
education intervention. Participants demonstrated improved scores for all constructs in the post-
survey that immediately followed the education tutorial. Despite the online PrEP tutorial taking 
only 30-40 minutes to complete, the NPs’ increased knowledge score was most impressive. The 
presentation’s evidence-based content in an easy to access, engaging format with practice 
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scenarios may have been an important factor in achieving positive knowledge gain results. This 
finding is in line with many studies that used longer PrEP training sessions (Irungu et al., 2019; 
Sales et al., 2019; Newman et al., 2019). Another recent study by Phillips et al. (2020) also found 
effectiveness of an education intervention administered in California’s federally qualified health 
centers. An impressive knowledge gain for all twelve providers with post-test scores of 90% or 
greater was noted after a weeklong comprehensive evidence-based PrEP training. More 
importantly, Phillips et al. (2020) found a significant increase of 67% in writing PrEP 
prescriptions. The study’s positive outcome reinforces the need for PrEP education and training 
aimed at frontline providers in primary care settings (Phillips et. al., 2020). Hence, the post- 
survey results echo the positive results that were found in previous studies and reinforces the 
need to provide education and training to NP providers. 
The third phase of the survey was unique to this PrEP Education project. Participants 
completed the retention survey anywhere from four to ten weeks after viewing the online PrEP 
tutorial. With only 31 subjects that participated in the 30-day retention survey, the mean 
knowledge score marginally declined (about 8%) between the post- and retention surveys. Since 
it is impossible to not forget newly acquired information, some loss of knowledge was to be 
expected. The infamous phenomenon discovered in the 1880s, the “Forgetting Curve” suggested 
that trainees forgot about 50% of the learned material in the first hour and about 70% within the 
first 2-hour period (Davidson, 2016). Hence, ongoing updates and educational refresher courses 
will be beneficial to retain and reinforce important clinical knowledge. Moreover, with a larger 
number of participants completing the retention survey, this study could have found the 
knowledge score loss not to exceed the 5%. The unexpected knowledge loss could also be related 
to the current pandemic that had affected the daily workflow. All clinics confronted revenue loss 
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with a very low number of daily patient visits as well as fewer patients seeking STI screening 
needs. At the same time, the organization focused on redirecting the clinic workflow to adopt 
new coronavirus-related services. All providers were inundated with new training material as 
well as adapting to the pandemic’s unprecedented workflow. 
Overall, participants demonstrated improved comfort screening “at-risk HIV” patients 
after viewing the PrEP education tutorial. However, there were no significant differences in 
providers’ pre-and post-survey ratings regarding their comfort in screening “at-risk HIV” 
patients. Likewise, Newman et al. (2019) found the medical residents’ comfort assessing PrEP’s 
clinical eligibility did not achieve a statistical significance despite their improved comfort 
prescribing PrEP after the 1-hour education session. The four-item section presented sensitive 
case scenarios of screening patients based on his/her gender and sexual preferences. By the third 
phase of the survey, NPs did increase their comfort level in asking the PrEP screening questions 
that explored patients’ sexual practices. Interestingly, the organization launched its updated HIV 
prophylaxis guideline in late September 2020. More emails and reminders about the updated 
clinical guideline were being announced just before the retention survey was sent out.  This 
could have encouraged providers to revisit their comfort level about the topic of PrEP and STI 
screenings. By the third phase of the survey, the participants increased their ratings for their 
comfort level to identify the “at-risk” HIV patients. Hence, this finding may be related to 
providers who had some time with repeated exposure to the PrEP topic that encouraged more 
consideration to become “comfortable” with this sensitive subject. 
  Participants’ confidence with PrEP prescribing practices showed improved scores 
throughout the survey phases. Indeed, the PrEP tutorial promoted knowledge about potential side 
effects and required laboratory data for ongoing PrEP follow-up visits. NPs' improved 
THE PREP EDUCATION INTERVENTION                 41 
confidence with PrEP prescribing practice suggested the knowledge gained about the national 
PrEP clinical guidelines. 
Participant responses to the likeliness to prescribe in the next six months showed 
favorable results. There was a steady increase for all phases of the survey. Compared to the 
baseline, participants were more likely to prescribe PrEP immediately following the intervention 
and 30 days following the intervention. Phillips et al. (2020) demonstrated a 67% increase in 
PrEP prescriptions following a week-long educational intervention based on the national PrEP 
clinical guideline. Although this QI project did not conduct a retrospective review of the 
organization’s electronic medical record, the study’s data signaled a promising perspective. This 
relevant finding suggested that participants did gain knowledge, comfort, and confidence related 
to PrEP practices after participating in the PrEP tutorial intervention. Their intent to confidently 
prescribe PrEP was recognized to symbolize improved care for the “at-risk HIV” patients. 
Educational Implications 
Nurse practitioners are lifelong learners that will seek ongoing education and training 
throughout their careers. Online education in various shapes and forms have become widely 
available and acceptable to meet the nursing professional needs and development. Quality online 
educational design that is engaging and interactive will be more suitable in engaging learners that 
promote a positive learning experience. Rouleau et al. (2019) conducted a systematic review on 
effects of e-learning on nursing care activities. Using the Kirkpatrick model’s levels of 
evaluation, Rouleau et al. (2019) found 59% of reviewed studies had positive outcomes related to 
e-learning. Specifically, e-learning interventions improved nurses’ knowledge in many subjects 
such as medication administration and calculation (Rouleau et al., 2019). Likewise, the PrEP 
tutorial’s interactive design with clinical case scenarios had a positive impact on NPs. When 
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compared to the pre-intervention baseline, NPs had learned many aspects about PrEP clinical 
practice that instilled their confidence and likeliness to prescribe PrEP in the near future. Overall, 
the online PrEP tutorial provided a low cost, yet robust way to educate NP providers about PrEP.   
Implications for Practice 
The PrEP education project’s findings supported the value of increasing providers’ 
knowledge through participation in an online training tutorial. Based on the CDC’s PrEP clinical 
guideline (CPG; CDC: U.S. Public Health Service, 2018), the self-paced online training had a 
significant impact on the organization and the community. Study results suggested that the Retail 
Clinic’s NPs were better equipped to engage in PrEP discussions with more patients with an 
improved ability to initiate PrEP. Their improved ability to screen for PrEP candidacy also 
implied their confidence with PrEP’s national CPG (CDC: U.S. Public Health Service, 2018). 
NPs’ increased understanding of PrEP is critical to delivering enhanced quality care 
for patients that may be “at-risk” for HIV.  Retail clinic NPs’ improved ability to offer safe 
PrEP related patient encounters ultimately benefits the communities and the nation. 
Instilling NPs with the knowledge to fuel comfort about screening candidacy and 
confidence about prescribing PrEP should reveal improved patient outcomes that predict 
lower HIV infection rates. 
Implications for Healthcare Policy 
The national initiative to dramatically lower HIV infections had spiraled the urgency for 
broader PrEP uptake. The “A Plan for America” involved prevention as one of its four key 
strategies along with “diagnosis,” “treatment” and “respond” themes. Under the prevention topic, 
PrEP was highlighted with an emphasis on the national clinical PrEP guideline, educational 
campaigns, and the PrEP Locator program (CDC, 2020c). Interestingly, the Kaiser Family 
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Foundation’s report revealed that 34.8 billion was spent on HIV-related efforts in 2019 with only 
3% of the total federal budget towards domestic HIV prevention efforts (Kaiser Family 
Foundation, 2019). Since the national plan parallels the current HIV epidemic, more funding 
should be allocated towards education aimed at improving provider knowledge about PrEP and 
the CDC’s national clinical guideline. All primary care practices should encourage their frontline 
providers to engage in an online self-paced training opportunity that may enhance their current 
knowledge on PrEP clinical guidelines. Also, national credentialing organizations for nursing 
education may influence advanced practice nursing programs to make curriculum enhancements 
that mirror the current public health efforts. Nurse practitioner programs could easily incorporate 
a brief online PrEP module to improve NP students’ knowledge about PrEP clinical guidelines 
and their role in ending the HIV epidemic for the nation. 
Implications for Executive Leadership 
Clinical leaders must continuously evaluate evidence-based practice and disseminate 
research findings that reinforce new practice protocols. With any newer guideline updates, the 
education team should offer training sessions. Organizational leadership should provide the 
needed resources that are required to develop engaging education tutorials. Since certain 
sensitive health topics will require various forms of training, the executive leadership should 
make a PrEP tutorial available on its intranet for the newer providers. 
Implications for Quality/Safety 
Recent trends in healthcare highlight the urgency to provide safe patient care that can 
deliver measurably improved outcomes. Education tutorials that can enhance providers’ ability to 
convey better patient care should be recognized. The improved composite scores for knowledge, 
comfort, and confidence constructs suggest that NPs could influence better outcomes for patients 
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“at-risk” for HIV.  With improved ability to screen for candidacy, NPs will be knowledgeable 
about how to safely treat these patients prophylactically to prevent HIV infections. The “at-risk 
HIV” patients who meet the criteria for PrEP will receive safe quality-driven care. Measurable 
outcomes for communities will support the national goal to lower 75% of HIV infections by the 
year 2025 (HIV.gov, 2019). 
Limitations 
This quality improvement project delivered for two regions in the mid-Atlantic area of 
the country lacks the ability to generalize for the entire nation. The study’s findings pertained to 
one retail clinic organization’s small group of NPs that were not recruited through a random 
sampling method. Also, the current analysis cannot conclude which construct variable best 
predicts NPs’ likeliness to prescribe in the next six months. 
Plans for Sustainability 
This QI project’s tutorial should be available on the organization’s intranet site. Other NP 
staff pursuing DNP degrees will have the opportunity to learn about the details of the study. The 
tutorial link can be available to offer to new onboarding staff who are new to retail clinic or 
newly graduated from NP programs. Other possible ideas for further dissemination of the PrEP 
tutorial are to current family practice nurse practitioner students who are in their final semester 
ready to graduate from their programs and dissemination to local nurse practitioner organization 
chapters. 
Future Direction 
A larger random sample size from various regions of the country may provide better 
insight into the value of delivering an online PrEP tutorial for retail clinic nurse practitioners. 
Advanced statistical regression analysis could predict whether the knowledge, comfort, or 
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confidence construct might best influence NPs’ likeliness to prescribe PrEP. Additionally, 
retrospective analysis of aggregate patient data to evaluate the number of actual PrEP 
prescriptions would highlight further insight into the intervention’s impact on improving PrEP 
uptake. 
Conclusion 
Despite the proven efficacy of PrEP, the uptake has been less than desirable in 
confronting the HIV epidemic. The organization’s retail health clinics located throughout the 
communities are the “PrEP Providers” answering the nation’s call to reduce the HIV infections 
that disproportionately affect the southern part of the country, including the capital, Washington 
DC. The evidence-based PrEP Education Intervention online tutorial was designed to instill 
knowledge, comfort and confidence for busy frontline nurse practitioners. This quality 
improvement project successfully demonstrated improved post-intervention survey scores to 
reflect enhanced PrEP knowledge, comfort identifying at-risk HIV candidates, and confidence 
with PrEP prescribing practices. Moreover, an improved score for NPs’ likeliness to prescribe 
PrEP in the next six months signified increased opportunities to prescribe PrEP to the “at-risk 
HIV” patients. Hence, this intervention contributed to building a team of NP champions ready to 
conduct quality-driven PrEP encounters and prescribe PrEP for those meeting the criteria.
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• Strong branding; Retail 
clinics nationwide 
• Well-known for convenience 
and quality; high patient 
satisfaction rate 
• Innovative retail health concept 
using EBP clinical guidelines; 
experienced and engaged 
leadership 
• Dedicated clinicians; 
educational & professional 
advancement opportunities 
• Magnet status and encourages 
"new knowledge, innovation 
and improvements" 
• Inexperienced providers 
with knowledge and skill 
deficit 
• Busy clinic setting and little 
time to engage in new learning 
activities 
• Lack of NP interest with 
PrEP topic 
• Organization does not permit use 
of any deidentified patient data 
or revealing company name for 
DNP projects 
• No network of infectious 
disease specialists for potential 
referrals 
    
   
   
   













• DC with high HIV incidence rate 
• Increased public awareness 
about PrEP with the national 
HIV prevention effort 
• Projected population growth 
for DC metro region 
• Public familiarity with retail 
health clinics 
• Generic version of Truvada 
available 
• USPTF’s PrEP 
recommendation updated 
to an “A” rating 
 
• Uninsured patients unable 
to afford cost of clinic visits 
• Failure of Health Hub initiative 
to increase “young adult” health 
services 
• Decreased overall patient volume 
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skills after the 
training; also, did 
not measure the 
effect of training 
on quality of 
PrEP service 
delivered to the 
community 
Level II & 
B quality 
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Findings that help 












































believed PrEP was 
safe 62%; had fair 
or poor knowledge 
of side effects 
Post-test revealed 
- 94% believed 
PrEP was 




pre-test was 32% 
& post-test 
revealed 67% to 
prescribe in the 
next 6 months 











22% out of 45 
surveyed were 
not at all familiar 






prescribe PrEP - 
pre intervention 













students); pre & 
post surveys 
were not linked 
Level II & 
B quality 
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Findings that help 












































was M=3.26 vs 





patients at HIV 
risk was pre- 
M=8.11 vs post 
M=9.11, p =.007 
 
Only 19% of 
staff members 
had previously 
heard of PrEP 
and only 7% 











not train every 
staff member for 
each clinic 
Level II & 
B Quality 
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Findings that help 




































N/A “A” grade for the 
position that 
clinicians should 
offer PrEP to 








magnitude of net 
benefit 








practice; does not 
discuss lack of 
provider 
knowledge 
Level I & 
A Quality 
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Findings that help 












































































their likeliness to 
prescribe PrEP 






survey limited to 
military 





survey leading to 
survey-fatigue 
Level III & 
B Quality 
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Findings that help 






































































Pre and post 
intervention 
surveys were not 
matched; 
insufficient 





rate; qualified for 
post survey 
criteria was 




study was limited 
to one region of 
the country 
Level II & 
C Quality 
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Findings that help 






























prescribe PrEP vs 







HCP’s of South; 
Barriers and 











95% CI 54- 
77%); PrEP 
consultation 
(37%l 95% CI 
25-52%); PrEP 
prescription 
(24%; 95% CI 
17-32%) 
Publication 
biases – type 1 
errors; high 
heterogeneity of 















NPs & PAs into 
one grp) 
Level II & 
A quality 
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Appendix C 
Iowa Model Revised 
Figure 1. Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care 
 
 
(Iowa Model Collaborative, 2017) 
 
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 2015. 
For permission to use or reproduce, please contact the University of Iowa Hospitals and Clinics 
at 319-384-9098 
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Appendix D 
Project Team Members 
Table 1. PrEP Education Intervention Team Members 
 
 
Dr. Karen Whitt Primary Advisor 
Principal Investigator 
Dr. Laura Posey Secondary Advisor 
Kristina Jung, MSN Student Principal Investigator 
Linda Duquette-Petersen, MSN Regional Quality Lead – Region 23 
Carol Gibson, MSN Region 23 Fellow, Preceptor 
Hilary Summers-Royce, DNP Regional Quality Lead – Region 22 
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Appendix E 
 
GWU IRB Determination 
 






As frontline providers to the communities we serve, we nurse practitioners (NP) must confront 
the current HIV epidemic. The national initiative endorsed by the Centers for Disease Control 
and Prevention (2019), “Ending the HIV Epidemic: A Plan for America,” aims to reduce 75% of 
HIV infections in the next five years and 90% by the year 2030. Importantly, Washington DC 
had the highest incidence rate in the nation with 34.6% in 2018 (CDC, 2019)! 
 
According to the Centers for Disease Control and Prevention’s site, all MinuteClinic is identified 
under “PrEP Locator” listings. This means that our clinics should offer this service confidently 
as well as being confident to screen for those at-high HIV risk individuals. Although this 
education session is optional, I hope you can take the time to review the PrEP education session. 
I hope it may enhance your knowledge and confidence in providing PrEP encounters. 
 
 
Length of Education Session 
Delivered online 
25-30 minutes 
Online Presurvey 5-10 minutes 
Online Postsurvey 5-10 minutes 




Purpose of Learning Session To gain knowledge, comfort, and confidence 
with PrEP clinical practice that includes 
screening candidacy and prescribing PrEP 
Learning Objectives 1. Learn what PrEP is 
2. Learn about the potential adverse effects 
of PrEP 
3. Learn to assess patient’s risk of 
contracting HIV to determine PrEP 
candidacy 
4. Learn to evaluate patients’ clinical 
eligibility for PrEP 
5. Learn to prepare PrEP prescriptions with 
appropriate patient education and 
necessary follow-ups 
Centers for Disease Control and Prevention. (2019). HIV surveillance report (Volume 30) 
[Report]. cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018- 
vol-30.pdf
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Appendix G 
Intervention Methodology Map 
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Appendix H 
Intervention Timeline 
Table 2. PrEP Education Intervention Timeline 
 
Completion Date Planning Pre- 
Implementation 
Implementation Evaluation 
5/08/2020 Finalize DNP 
Project 
Proposal 




   





   




7/20/2020 Complete PP 
PrEP teaching 
material 




 Reconnect with 
SPMs to remind 
them about 
launching date 



















  Pre-survey 





  Launch the 
Education 
intervention 
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  PrEP Education 
w/ Post-survey 




















  Week 8 












  Invitational 







































Title of Study: The PrEP Education Intervention 
IRB #: 
Principal Investigator Name: Dr. Karen Whitt DNP Student Investigator: Kristina Jung 
Version Date:  1/4/2019 
 
You are invited to participate in a quality improvement project under the direction of Dr. 
Karen Whitt of the Department of Nursing, George Washington University (GWU). 
Taking part in this research is entirely voluntary. Further information regarding this study 
may be obtained by contacting Kristina Jung (DNP Student Investigator) at 
(703) 615-4300. 
 
The purpose of this project is to evaluate clinic nurse practitioners in assessing and 
prescribing PrEP. Participants will receive an educational intervention aimed at 
increasing provider knowledge of PrEP to help improve screening and prophylaxis 
preexposure HIV in at-risk individuals. 
 
What are the reasons you might choose to volunteer for this project? The PrEP education 
session will be provided online, at your convenience and will refresh your knowledge 
about PrEP practice that includes identifying those at-HIV risk and safe prescribing. 
Your participation also supports the national movement “Ending the HIV Epidemic: A 
Plan for America,” which aims to reduce 75% of HIV infections in the next five years 
and 90% by the year 2030. 
 
What are the reasons you might not choose to volunteer for this project? 
It does require some attention and time commitment to attend the education session 
and complete the surveys. 
 
If you choose to take part in this project, you will answer the presurvey, view the 
PowerPoint learning module and answer the postsurvey. One month later, you will be 
asked to answer the post survey again to test for knowledge retention. The total 
amount of time you will spend in connection with this project is 20-30 minutes. The second 
postsurvey will take additional 10-15 minutes. You may refuse to answer any of the 
questions, and you may stop your participation in this project at any time. 
 
Possible risks or discomforts you could experience during this project include: The risks for 
participating in this project are minimal and no more than encountered in daily life. 
The main risk would be confidentiality of your answers on the surveys. All survey 
answers will only be accessible to the investigator, Kristina Jung, and 
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individual names and answers will not be kept confidential. Results from the survey 
will only be reported in aggregated, anonymous form. 
 
You will not benefit directly from your participation in the project. The benefits to science 
and humankind that might result from this study are: It may further support the need for 
PrEP education for American frontline providers. PrEP education may improve 
knowledge, comfort and confidence for PrEP related practice, as well as, increasing 
the willingness to prescribe to those at-risk HIV patients. Frontline providers, 
equipped with improved knowledge and confidence, may improve the care delivered 
to the at-risk HIV patient population. 
 
Every effort will be made to keep your information confidential, however, this cannot be 
guaranteed. You will be asked to include your name on the survey, but only the 
investigator, Kristina Jung, will have access to this information. After initial data is 
collected your name will be replaced with an anonymous number. If results of this 
research study are reported in journals or at scientific meetings, the people who participated 
in this project will not be named or identified. 
 
The Office of Human Research of George Washington University, at telephone number 
(202) 994-2715, can provide further information about your rights as a research participant. 
 
To ensure anonymity your signature is not required. Your willingness to participate in 
this project is implied if you proceed with completing the surveys. 
*Please keep a copy of this document in case you want to read it again. 
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Appendix J 
PrEP Education Survey 
 
 




Age in years    
 
How many years of experience do you have as a Nurse Practitioner?      
 
What is your Race/ Ethnicity? 
1 = White/ Non-Hispanic 
2 = African American 
3 = Asian 
4 = Other 
 
What is your highest degree of education? 
1 = MSN or master’s degree 
2 = DNP/ Doctorate 
 
What is your gender? 
1 = Female 
2 = Male 
 
“Prior PrEP Experience” 
 












4) Have you ever prescribed PrEP to a 
patient? 1=Yes 
2=No 
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Provider Knowledge – 10 questions 
 
1) Which medication has been FDA-approved for PrEP use? (FDA) 
a) Maraviroc (Selzentry) 
b) Tenofovir 
c) Tenofovir / Emtricitabine (Truvada)* 
d) Tenofovir / Emtricitabine / Efavirenz (Atripla) 
e) Raltegravir + Emtracitabine (Isentress + Emtriva) 
f) None has been approved 
g) Not Sure 
 
PrEP Knowledge Survey item 
 
2) How often should patients on PrEP be followed for medication side effects and lab 
toxicities after initial assessment? (PrEP Monitor) 
a) Every month 
b) Every 6 months 
c) Every 3 months 
d) Yearly 
e) Not necessary to monitor after the first year 
 
3) You are discussing PrEP with a 30-year-old male who has multiple male sexual partners. 
He states he seldom wears a condom. Which clinical eligibility factors do not support the 
initiation of PrEP? 
 
a) HIV negative status, no active signs/symptoms of HIV infection, GFR > 60 
b) HIV negative status, negative Anti-HBs, Negative Hep C antibody, GFR<60 
c) HIV negative status, no active signs/symptoms of HIV infection, Positive HBsAg, 
GFR>60 
d) HIV negative status, Negative HBsAg, no fever, fatigue, pharyngitis, rash, night 
sweats and adenopathy 
 
4) Can an individual be initiated on PrEP after becoming exposed to HIV? 
 
a) Yes. PrEP can be initiated within 72 hours of becoming exposed to HIV 
b) No. PrEP must be initiated for HIV negative individuals only 
c) Yes. PrEP can be taken for up to 7 days 
d) Only Descovy can be started under this circumstance 
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5) What are the serious side effects of PrEP? 
 
a) Increased bone mineral density 
b) Increased buildup of calcium deposits 
c) Mild nausea and diarrhea 
d) New or worsening renal impairment, including kidney failure 
 
6) How effective do you think PrEP is in preventing acquisition of HIV among people who 
take it every day as prescribed? 





7) Based on your understanding of PrEP side effects, how safe is PrEP? 





8) PrEP reaches maximum protection from HIV for receptive anal sex at about how many 
days of daily use? 
a) 3 days of daily use 
b) 4 days of daily use 
c) 6 days of daily use 
d) 7 days of daily use 
 
9) For receptive vaginal sex and injection drug use, PrEP reaches maximum protection at 
about how many days of daily use. 
a) 7 days of daily use 
b) 14 days of daily use 
c) 21 days of daily use 
d) 28 days of daily use 
 
10) If a patient says he/she is using condoms consistently and correctly, how important is it to 
offer PrEP in addition to condoms if you have identified the individual as possessing high 
at-risk HIV? 
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Provider Comfort Level - 4 questions 
 
1) For each of the following risk behavior categories, how comfortable are you 
evaluating eligibility for PrEP? 
 
How comfortable are you evaluating PrEP eligibility for Women who have sex with 
men? 
1= Not at all comfortable 
 2= Slightly comfortable 
3= Moderately comfortable 
4= Extremely comfortable 
 
2) How comfortable are you evaluating PrEP eligibility for Men who have sex with 
women? 
1= Not at all comfortable 
2= Slightly comfortable 
3= Moderately comfortable 
4= Extremely comfortable 
 
3) How comfortable are you evaluating PrEP eligibility for Men who have sex with men? 
1= Not at all comfortable 
2= Slightly comfortable 
3= Moderately comfortable 
4= Extremely comfortable 
 
4) How comfortable are you evaluating PrEP eligibility for People who inject drugs? 
1= Not at all comfortable 
2= Slightly comfortable 
3= Moderately comfortable 
4= Extremely comfortable 
 
Provider Confidence - 8 questions 
 
Each of the following risk behavior categories, how confident are you to prescribe PrEP to an 
eligible individual, assuming a recent negative HIV test and equal access to medication. 
 
1) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a female with a current male partner known to be HIV- 
positive? 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
2) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a female who has unprotected sex with male partners with 
THE PREP EDUCATION INTERVENTION                  80 
unknown HIV status who are at high risk of HIV infection (e.g. partners(s) who has 
sex with other males or uses injection drugs)? 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
3) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a male with a current female partner known to be HIV- 
positive? 
 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
4) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to A male who has unprotected sex with male partners with 
unknown HIV status who are at high risk of HIV infection (e.g., partner(s) who has sex 
with other males or uses injection drugs)? 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
5) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a male with a current male partner known to be HIV- 
positive? 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
6) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a male who has sex with multiple male partners and has had 
unprotected anal sex? 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
7) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a person who has injected drugs in the past 6 months and 
shared injection equipment? 
1= Not at all confident 
2= Slightly confident 
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3= Moderately confident 
4= Extremely confident 
 
8) Assuming a recent negative HIV test and equal access to medication, how confident are 
you to prescribe PrEP to a person who has been on methadone maintenance for the 
past 6 months but has continued injection drug use? 
1= Not at all confident 
2= Slightly confident 
3= Moderately confident 
4= Extremely confident 
 
Provider likeliness to prescribe 
 
1) How likely are you to prescribe PrEP in the next 6 months? 
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Appendix K 
Variable Table 








NP Identifier Alpha- 
numeric, 
discrete 




NP Age Demographic Self-reported Age 
in years 
Age in actual years Continuous 
NP years of 
experience as a 
provider 
Demographic Self-reported 
Years of NP 
experience 
Number of years 







1 = White/ Non- 
Hispanic 
2 = African 
American 
3 = Asian 





highest degree of 
nursing education 
Categorical: 
1 = MSN 




NP Gender Demographic Self-reported 
gender 
Categorical: 
1 = Female 





had you heard 
of PrEP? 









PrEP by a 
Patient? 
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PrEP to a 
Patient? 
    
Before today, Demographi
c 
Provider Likert scale” Categorical 
how would  knowledge of 1=Poor  
you rate your  PrEP’s potential 2=Fair  
knowledge of  side effects 3=Good  
PrEP’s   4=Very good  
potential side   5=Excellent  
effects?     
PrEP clinical Dependent Total score for all Numerical scale & Ratio (%) 
practice  knowledge ratio Continuous Scale 
knowledge  construct questions The sum of the (raw score) 
composite   number of correct  
measured at pre, 
post and 30-day 
follow- up 
  answers on 7 
multiple choice 




   knowledge  
   Total possible  
   score of 19.  
Comfort Dependent Total score for all The sum of the Ratio (%) 
identifying  comfort construct numeric self-rated Continuous Scale 
PrEP eligible  questions answers on 4 (raw score) 
patients   question’s rating  
composite   comfort on a 4-  
score measured   point Likert scale.  
at pre, post and   Total possible  
30-day follow-up   score of 16.  
Confidence Dependent Total score for all The sum of the Ratio (%) 
prescribing  confidence numeric self-rated Continuous Scale 
PrEP  construct answers on 8 (raw score) 
composite  questions. questions rating  
score measured   confidence on a 4-  
at pre, post and   point Likert scale.  
30-day follow-up   Total possible  
   score of 32.  
NP likelihood Dependent NP self- Likert Scale: Ordinal 
to prescribe  determined 1= Not at all  
PrEP in 6 months  likelihood to 2= Slightly  
measured at 
pre & post 





    
     





Data Element Data Label Data Type Definition/Purpose Data Values & Coding 
Participant Identifier Token Alpha-numeric Personal identifier – 6 
digits in length 
Alpha-numeric 
Employment Status Empstatus Categorical Descriptive Item: 
What is your 
employment status? 
1, Full time; 2, Regular Part time; 3, 
Casual/ Committed Part time; 4, 
Management and/or education 
Gender gender Categorical Descriptive Item: What 
is your gender? 
1, female; 2, male 
Age age Numeric, 
continuous 
Descriptive Item: 
What is your age? 
Actual numeric value 
NP Experience NPexper Numeric, 
continuous 
Descriptive Item: 
How many years of 
experience do you have 
as a Nurse Practitioner? 
Actual numeric value 
Race/Ethnicity race Categorical Descriptive Item: 
What is your Race/ 
Ethnicity? 
1, African American or Black; 
2, Asian; 3, Hispanic or Latino; 4, 
White/Non-Hispanic; 5, Other 
nursing education lvl nursingedlvl Categorical Descriptive Item: 
What is your highest 
degree of nursing 
education? 
1, MSN or master’s degree; 2, 
DNP/ doctorate 
Ever heard of PrEP EverPrEP Categorial Descriptive Item: 
Before today, had you 
heard of PrEP? 
1, Yes; 2, No 
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Ever been asked about 
PrEP by a patient 
askedabtprep Categorical Descriptive Item: 
Have you ever been 
asked about PrEP by a 
patient? 
1, Yes; 2, No 
Ever initiated PrEP 
topic with a patient 
initiateconv Categorical Descriptive Item: 
Have you ever initiated 
a conversation about 
PrEP with patient? 
1, Yes; 2, No 
Ever prescribed 
PrEP to a patient? 
prescribePrEP Categorical Descriptive Item: Have 
you ever prescribed 
PrEP to a patient? 




SEknowl Categorical Descriptive Item: 
Before today, how 
would you rate your 
knowledge of PrEP’s 
potential side effects 
(e.g. renal dysfunction)? 
1, Excellent; 2, Very good; 3, Good; 4, 
Fair; 5, Poor 






Which medication has 
been FDA-approved for 
PrEP use? 
Maraviroc (Selzentry); Tenofovir; 
Tenofovir/ Emtricitabine (Truvada); 
Tenofovir/ Emtricitabine/ Efavirenz 
(Atripla); Raltegravir + Emtracitabine 
(Isentress + Emtriva); none approved; 
not sure 





1, correct response; 
0, incorrect response 






How often should 
patients on PrEP be 
followed up for 
medication side effects 
Every month; Every 6 months; Every 
3 months; Yearly; Not necessary after 
first year 
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   and lab work-up after 
the initial assessment? 
 
Correct preK2 answer CorrectpreK2 Categorical 
Nominal 
Answer: 
Every 3 months 
1, correct response; 
0, incorrect response 
PreK3 Clinical 
eligibility does not 






You are assessing recent 
lab results for a 30-year- 
old male patient with 
significant risk for HIV. 
Which set of clinical 
eligibility factors does 
not support the 
initiation of PrEP 
(Truvada) at this time? 
1, HIV negative status, no active 
signs/ symptoms of HIV infection. 
Positive HBsAg, GFR>60 ; 2, HIV 
negative status, negative Anti-HBS, 
Negative Hep C antibody, GFR<60; 
3, HIV negative status, no active 
signs/ symptoms of HIV infection, 
GFR>60; 4, HIV negative status, 
Negative HBsAg, no fever, fatigue, 
pharyngitis, rash, night sweats and 
adenopathy 






Hep C antibody, 
GR<60 
1, correct response; 
0, incorrect response 






Can an individual be 
initiated on PrEP after 
becoming exposed to 
HIV? 
1, Yes. PrEP can be initiated within 
72 hours of becoming exposed to 
HIV; 2, No. PrEP must be initiated for 
HIV negative individuals only, 3, 
Yes. PrEP can be taken for up to 7 
days; 4, Only 
Descovy can be started under this 
circumstance 
Correct preK4 answer CorrectpreK4 Categorical 
Nominal 
Answer: 
No. PrEP must 
be initiated for 
HIV 
1, correct response; 
0, incorrect response 
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   negative individuals 
only 
 






What are the serious 
side effects of PrEP? 
1, Increased bone mineral density; 2, 
Increased buildup of calcium 
deposits; 3, mild nausea and diarrhea; 
4, New or worsening renal 
impairment, including kidney failure 
Correct preK5 answer CorrectpreK5 Categorical 
Nominal 
Answer: 
New or worsening renal 
impairment, including 
kidney failure 
1, correct response; 







How effective do you 
think PrEP is in 
preventing acquisition 
of HIV among people 
who take it every day as 
prescribed? 
1, Not at all effective; 2, Slightly 
effective; 3, Moderately effective; 4, 
Extremely effective 
Correct preK6 answer CorrectpreK6 Categorical 
Nominal 
Answer: 
4= Extremely Effective 
1, correct response; 
0, incorrect response 




Based on your 
understanding of PrEP 
side effects, how safe is 
PrEP? 
1, Not at all safe; 2, Slightly safe; 
3, Moderately safe; 4, Extremely 
safe 




1, correct response; 
0, incorrect response 
PreK8 Maximum 






1, 3 days of daily use; 2, 4 days of 
daily use; 3, 6 days of daily use; 4, 
7 days of daily use 
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   PrEP reaches maximum 
protection from HIV for 
receptive anal sex at 
about how many days of 
daily use? 
 
Correct preK8 answer CorrectpreK8 Categorical 
Nominal 
Answer: 
7 days of daily use 
1, correct response; 









For receptive vaginal 
sex and injection drug 
use, PrEP reaches 
maximum protection at 
about how many days 
of daily use? 
1, 7 days of daily use; 2, 14 days of 
daily use; 3, 21 days of daily use; 4, 
28 days of daily use 
Correct preK9 answer CorrectpreK9 Categorical 
Nominal 
Answer: 
21 days of daily use 
1, correct response; 
0, incorrect response 
PreK10 Importance of 





If a patient says he/she 
is using condoms 
consistently and 
correctly, how important 
is it to offer PrEP in 
addition to condoms if 
you have identified the 
individual as possessing 
high at-risk HIV? 
1, Not at all important; 2, Slightly 
important; 3, Moderately important; 
4, Extremely important 




1, correct response; 
0, incorrect response 
Total PreK score PreK score Numerical 
Discrete 
Total number of correct 
responses 
Each point for each of the correct 
responses for total of 10 points 
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Pre Comfort with 
evaluation for women 
having sex with men 
preComf1 Categorical 
Ordinal 
Presurvey Comfort item 
#1: 
How comfortable are 
you evaluating PrEP 
eligibility for Women 
who have sex with 
men? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Pre Comfort with 
evaluation for men 




Presurvey Comfort item 
#2: 
How comfortable are 
you evaluating PrEP 
eligibility for Men who 
have sex with women 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Pre Comfort with 
evaluation for men 
having sex with men 
preComf3 Categorical 
Ordinal 
Presurvey Comfort item 
#3: 
How comfortable are 
you evaluating PrEP 
eligibility for Men who 
have sex with men? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Pre Comfort with 
evaluation for people 
who inject drugs 
preComf4 Categorical 
Ordinal 
Presurvey Comfort item 
#4: 
How comfortable are 
you evaluating PrEP 
eligibility for People 
who inject drugs? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Pre Comfort Score PreComfscore Numerical 
Discrete 
Total cumulative score 
for Comfort related 
questions 
Total possible points from 4 to 16 
numeric points 
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Pre Confidence to 
prescribe PrEP to a 
female who has HIV 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
female with a current 
male partner known to 
be HIV-positive? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Pre Confidence to 
prescribe PrEP to a 
female who has sex 
with unknown HIV 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
female who has 
unprotected sex with 
male partners with 
unknown HIV status 
who are at high risk of 
HIV infection (e.g. 
partners(s) who has sex 
with other males or uses 
injection drugs)? 
1, not at all; 2, slightly confident; 3, 
moderately confident; 4, extremely 
confident 
Pre Confidence to 
prescribe PrEP to a 





1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 




  Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
with a current female 
partner known to be 
HIV-positive? 
 
Pre Confidence to preCon4 Categorical Presurvey Confidence 
item #4: 
Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to A 
male who has 
unprotected sex with 
male partners with 
unknown HIV status 
who are at high risk of 
HIV infection (e.g., 
partner(s) who has sex 
with other males or uses 
injection drugs)? 
1, not at all confident; 2, slightly 
prescribe PrEP to a  Ordinal confident; 3, moderately confident; 4, 
male who has   extremely confident 
unprotected sex with    
male partners with    
unknown HIV status    
Pre Confidence to preCon5 Categorical Presurvey Confidence 1, not at all confident; 2, slightly 
prescribe PrEP to a 
male with a current 
HIV positive 
male partner 
 Ordinal item #5: 
Assuming a recent 
negative HIV test and 
equal access to 
confident; 3, moderately confident; 4, 
extremely confident 
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   medication, how 
confident are you to 
prescribe PrEP to a male 
with a current male 
partner known to be 
HIV-positive? 
 
Pre Confidence to preCon6 Categorical Presurvey Confidence 
item #6: 
Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
who has sex with 
multiple male partners 
and has had unprotected 
anal sex? 
1, not at all confident; 2, slightly 
prescribe PrEP to a  Ordinal confident; 3, moderately confident; 4, 
male who has sex with   extremely confident 
multiple male partners    
and has had    
unprotected anal sex    
Pre Confidence to preCon7 Categorical Presurvey Confidence 
item #7: 
Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
person who has injected 
drugs in the past 6 
months and shared 
injection equipment? 
1, not at all confident; 2, slightly 
prescribe PrEP to a  Ordinal confident; 3, moderately confident; 4, 
person who has   extremely confident 
injected drugs in the    
past 6 months and    
shared injection    
equipment    
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Pre Confidence to 
prescribe PrEP to a 
person who has been 
on methadone 
maintenance for the 







Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
person who has been on 
methadone maintenance 
for the past 6 months 
but has continued 
injection drug use? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 




Total score of all pre 
Confidence related 
responses 
Total possible points 8 to 32 numeric 
points 
Pre-Likeliness to 
prescribe PrEP in 
next 6 months 
Pre_prescribe Ordinal Presurvey item: How 
likely are you to 
prescribe PrEP in the 
next 6 months? 
1, not at all; 2, slightly; 3, moderately; 
4, extremely 






Which medication has 
been FDA-approved for 
PrEP use? 
1, Maraviroc (Selzentry); 2, 
Tenofovir; 3, Tenofovir/ Emtricitabine 
(Truvada); 4, Tenofovir/ 
Emtricitabine/ Efavirenz (Atripla); 5, 
Raltegravir + Emtracitabine (Isentress 
+ Emtriva) 6, none approved; 7, not 
sure 





1, correct response; 
0, incorrect response 
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How often should 
patients on PrEP be 
followed up for 
medication side effects 
and lab work-up after 
the initial assessment? 
1, Every month; 2, Every 6 months, 3, 
Every 3 months, 4, Yearly, 5, Not 
necessary after first year 
Correct postK2 answer CorrectpostK2 Categorical 
Nominal 
Answer: 
Every 3 months 
1, correct response; 
0, incorrect response 
PostK3 Clinical 
eligibility does not 






You are assessing recent 
lab results for a 30-year- 
old male patient with 
significant risk for HIV. 
Which set of clinical 
eligibility factors does 
not support the 
initiation of PrEP 
(Truvada) at this time? 
1, HIV negative status, no active 
signs/ symptoms of HIV infection. 
Positive HBsAg, GFR>60 ; 2, HIV 
negative status, negative Anti-HBS, 
Negative Hep C antibody, GFR<60; 
3, HIV negative status, no active 
signs/ symptoms of HIV infection, 
GFR>60; 4, HIV negative status, 
Negative HBsAg, no fever, fatigue, 
pharyngitis, rash, night sweats and 
adenopathy 






Negative Hep C 
antibody, 
GR<60 
1, correct response; 
0, incorrect response 






Can an individual be 
initiated on PrEP after 
becoming exposed to 
HIV? 
1, Yes. PrEP can be initiated within 
72 hours of becoming exposed to 
HIV; 2, No. PrEP must be initiated for 
HIV negative individuals only, 3, 
Yes. PrEP can be taken for up to 7 
days; 4, Only 
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    Descovy can be started under this 
circumstance 
Correct postK4 answer CorrectpostK4 Categorical 
Nominal 
Answer: 
No. PrEP must be 
initiated for HIV 
negative individuals 
only 
1, correct response; 
0, incorrect response 






What are the serious 
side effects of PrEP? 
1, Increased bone mineral density; 2, 
Increased buildup of calcium 
deposits; 3, mild nausea and diarrhea; 
4, New or worsening renal 
impairment, including kidney failure 
Correct postK5 answer CorrectpostK5 Categorical 
Nominal 
Answer: 
New or worsening renal 
impairment, including 
kidney failure 
1, correct response; 







How effective do you 
think PrEP is in 
preventing acquisition 
of HIV among people 
who take it every day as 
prescribed? 
1, Not at all effective; 2, Slightly 
effective; 3, Moderately effective; 4, 
Extremely effective 
Correct postK6 answer CorrectpostK6 Categorical 
Nominal 
Answer: 
4= Extremely Effective 
1, correct response; 
0, incorrect response 




Based on your 
understanding of PrEP 
side effects, how safe is 
PrEP? 
1, Not at all safe; 2, Slightly safe; 
3, Moderately safe; 4, Extremely 
safe 
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1, correct response; 
0, incorrect response 
PostK8Maximum 






PrEP reaches maximum 
protection from HIV for 
receptive anal sex at 
about how many days of 
daily use? 
1, 3 days of daily use; 2, 4 days of 
daily use; 3, 6 days of daily use; 4, 
7 days of daily use 
Correct postK8 answer CorrectpostK8 Categorical 
Nominal 
Answer: 
7 days of daily use 
1, correct response; 
0, incorrect response 
PostK9Maximu
m protection 





For receptive vaginal 
sex and injection drug 
use, PrEP reaches 
maximum protection at 
about how many days 
of daily use? 
1, 7 days of daily use; 2, 14 days of 
daily use; 3, 21 days of daily use; 4, 
28 days of daily use 
Correct postK9 answer CorrectpostK9 Categorical 
Nominal 
Answer: 
21 days of daily use 
1, correct response; 
0, incorrect response 
PostK10Importance of 





If a patient says he/she 
is using condoms 
consistently and 
correctly, how important 
is it to offer PrEP in 
addition to condoms if 
you have identified the 
individual as possessing 
high at-risk HIV? 
1, Not at all important; 2, Slightly 
important; 3, Moderately important; 
4, Extremely important 
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1, correct response; 
0, incorrect response 
Total post Kscore PostKscore Numerical 
Discrete 
Total number of correct 
responses 
Each point for each of the correct 
responses for total of 10 points 
Post Comfort with 
evaluation for women 





How comfortable are 
you evaluating PrEP 
eligibility for Women 
who have sex with 
men? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Post Comfort with 
evaluation for men 






How comfortable are 
you evaluating PrEP 
eligibility for Men who 
have sex with women? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Post Comfort with 
evaluation for men 





How comfortable are 
you evaluating PrEP 
eligibility for Men who 
have sex with men? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Post Comfort with 
evaluation for people 





How comfortable are 
you evaluating PrEP 
eligibility for People 
who inject drugs? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
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Post Comf Score PostComfscore Numerical 
Discrete 
Total cumulative score 
for Comfort related 
questions 
Total possible points from 4 to 16 
numeric points 
Post Confidence to 
prescribe PrEP to a 
female who has HIV 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
female with a current 
male partner known to 
be HIV-positive? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Post Confidence to 
prescribe PrEP to a 
female who has sex 
with unknown HIV 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
female who has 
unprotected sex with 
male partners with 
unknown HIV status 
who are at high risk of 
HIV infection (e.g. 
partners(s) who has sex 
with other males or uses 
injection drugs)? 
1, not at all; 2, slightly confident; 3, 
moderately confident; 4, extremely 
confident 
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Post Confidence to 
prescribe PrEP to a 







Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
with a current female 
partner known to be 
HIV-positive? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Post Confidence to 
prescribe PrEP to a 
male who has 
unprotected sex with 
male partners with 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to A 
male who has 
unprotected sex with 
male partners with 
unknown HIV status 
who are at high risk of 
HIV infection (e.g., 
partner(s) who has sex 
with other males or uses 
injection drugs)? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Post Confidence to 
prescribe PrEP to a 





1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 




  Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
with a current male 
partner known to be 
HIV-positive? 
 
Post Confidence to postCon6 Categorical Postsurvey Confidence 
item #6: 
Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
who has sex with 
multiple male partners 
and has had unprotected 
anal sex? 
1, not at all confident; 2, slightly 
prescribe PrEP to a  Ordinal confident; 3, moderately confident; 4, 
male who has sex with   extremely confident 
multiple male partners    
and has had    
unprotected anal sex    
Post Confidence to postCon7 Categorical Postsurvey Confidence 
item #7: 
Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
person who has injected 
drugs in the past 6 
1, not at all confident; 2, slightly 
prescribe PrEP to a  Ordinal confident; 3, moderately confident; 4, 
person who has   extremely confident 
injected drugs in the    
past 6 months and    
shared injection    
equipment    
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   months and shared 
injection equipment? 
 
Post Confidence to 
prescribe PrEP to a 
person who has been 
on methadone 
maintenance for the 







Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
person who has been on 
methadone maintenance 
for the past 6 months 
but has continued 
injection drug use? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 




Total score of all post 
Confidence related 
responses 
Total possible points 8 to 32 numeric 
points 
Post-Likeliness to 
prescribe PrEP in 
next  6 months 
Post prescribe Ordinal Postsurvey item: How 
likely are you to 
prescribe PrEP in the 
next 6 months? 
1, not at all; 2, slightly; 3, moderately; 
4, extremely 






Which medication has 
been FDA-approved for 
PrEP use? 
1, Maraviroc (Selzentry); 2, 
Tenofovir; 3, Tenofovir/ Emtricitabine 
(Truvada); 4, Tenofovir/ 
Emtricitabine/ Efavirenz (Atripla); 5, 
Raltegravir + Emtracitabine (Isentress 
+ Emtriva) 6, none approved; 7, not 
sure 
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1, correct response; 
0, incorrect response 






How often should 
patients on PrEP be 
followed up for 
medication side effects 
and lab work-up after 
the initial assessment? 
1, Every month; 2, Every 6 months, 3, 
Every 3 months, 4, Yearly, 5, Not 
necessary after first year 
Correct ReK2 answer CorrectReK2 Categorical 
Nominal 
Answer: 
Every 3 months 
1, correct response; 
0, incorrect response 
ReK3 Clinical 
eligibility not support 





You are assessing recent 
lab results for a 30-year- 
old male patient with 
significant risk for HIV. 
Which set of clinical 
eligibility factors does 
not support the 
initiation of PrEP 
(Truvada) at this time? 
1, HIV negative status, no active 
signs/ symptoms of HIV infection. 
Positive HBsAg, GFR>60 ; 2, HIV 
negative status, negative Anti-HBS, 
Negative Hep C antibody, GFR<60; 
3, HIV negative status, no active 
signs/ symptoms of HIV infection, 
GFR>60; 4, HIV negative status, 
Negative HBsAg, no fever, fatigue, 
pharyngitis, rash, night sweats and 
adenopathy 






Hep C antibody, 
GR<60 
1, correct response; 
0, incorrect response 






1, Yes. PrEP can be initiated within 72 
hours of becoming exposed to HIV; 2, 
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   Can an individual be 
initiated on PrEP after 
becoming exposed to 
HIV? 
No. PrEP must be initiated for HIV 
negative individuals only, 3, Yes. 
PrEP can be taken for up to 7 days; 4, 
Only Descovy can be started under 
this 
circumstance 
Correct ReK4 answer CorrectReK4 Categorical 
Nominal 
Answer: 
No. PrEP must be 
initiated for HIV 
negative individuals 
only 
1, correct response; 
0, incorrect response 






What are the serious 
side effects of PrEP? 
1, Increased bone mineral density; 2, 
Increased buildup of calcium 
deposits; 3, mild nausea and diarrhea; 
4, New or worsening renal 
impairment, including kidney failure 
Correct ReK5 answer CorrectReK5 Categorical 
Nominal 
Answer: 
New or worsening renal 
impairment, including 
kidney failure 
1, correct response; 







How effective do you 
think PrEP is in 
preventing acquisition 
of HIV among people 
who take it every day as 
prescribed? 
1, Not at all effective; 2, Slightly 
effective; 3, Moderately effective; 4, 
Extremely effective 
Correct ReK6 answer CorrectReK6 Categorical 
Nominal 
Answer: 
4= Extremely Effective 
1, correct response; 
0, incorrect response 




1, Not at all safe; 2, Slightly safe; 3, 
Moderately safe; 4, Extremely safe 
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   Based on your 
understanding of PrEP 
side effects, how safe is 
PrEP? 
 




1, correct response; 
0, incorrect response 
ReK8 Maximum 






PrEP reaches maximum 
protection from HIV for 
receptive anal sex at 
about how many days of 
daily use? 
1, 3 days of daily use; 2, 4 days of 
daily use; 3, 6 days of daily use; 4, 
7 days of daily use 
Correct ReK8 answer CorrectReK8 Categorical 
Nominal 
Answer: 
7 days of daily use 
1, correct response; 









For receptive vaginal 
sex and injection drug 
use, PrEP reaches 
maximum protection at 
about how many days 
of daily use? 
1, 7 days of daily use; 2, 14 days of 
daily use; 3, 21 days of daily use; 4, 
28 days of daily use 
Correct ReK9 answer CorrectReK9 Categorical 
Nominal 
Answer: 
21 days of daily use 
1, correct response; 
0, incorrect response 
ReK10 Importance of 





If a patient says he/she 
is using condoms 
consistently and 
correctly, how important 
is it to offer PrEP in 
1, Not at all important; 2, Slightly 
important; 3, Moderately important; 
4, Extremely important 
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   addition to condoms if 
you have identified the 
individual as possessing 
high at-risk HIV? 
 




1, correct response; 
0, incorrect response 
Total Retention Kscore ReKscore Numerical 
Discrete 
Total number of correct 
responses 
Each point for each of the correct 
responses for total of 10 points 
Retention Comfort 
with evaluation for 




Retention Comfort item 
#1: 
How comfortable are 
you evaluating PrEP 
eligibility for Women 
who have sex with 
men? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Retention Comfort 
with evaluation for 




Retention Comfort item 
#2: 
How comfortable are 
you evaluating PrEP 
eligibility for Men who 
have sex with women 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Retention Comfort 
with evaluation for 




Retention Comfort item 
#3: 
How comfortable are 
you evaluating PrEP 
eligibility for Men who 
have sex with men? 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
Retention Comfort 
with evaluation for 




Retention Comfort item 
#4: 
How comfortable are 
you evaluating PrEP 
1, not at all comfortable; 2, slightly 
comfortable; 3, moderately 
comfortable; 4, extremely 
comfortable 
THE PREP EDUCATION INTERVENTION                              106  
 
   eligibility for People 
who inject drugs: 
 
Retention Comf Score ReComfscore Numerical 
Discrete 
Total cumulative score 
for Comfort related 
questions 
Total possible points from 4 to 16 
numeric points 
Retention Confidence 
to prescribe PrEP to a 
female who has HIV 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
female with a current 
male partner known to 
be HIV-positive? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Retention Confidence 
to prescribe PrEP to a 
female who has sex 
with unknown HIV 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
female who has 
unprotected sex with 
male partners with 
unknown HIV status 
who are at high risk of 
HIV infection (e.g. 
partners(s) who has sex 
1, not at all; 2, slightly confident; 3, 
moderately confident; 4, extremely 
confident 
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to prescribe PrEP to a 
male with a current 






Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
with a current female 
partner known to be 
HIV-positive? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Retention Confidence 
to prescribe PrEP to a 
male who has 
unprotected sex with 
male partners with 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to A 
male who has 
unprotected sex with 
male partners with 
unknown HIV status 
who are at high risk of 
HIV infection (e.g., 
partner(s) who has sex 
with other males or uses 
injection drugs)? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
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Retention Confidence 
to prescribe PrEP to a 
male with a current 






Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
with a current male 
partner known to be 
HIV-positive? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Retention Confidence 
to prescribe PrEP to a 
male who has sex with 
multiple male partners 
and has had 





Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a male 
who has sex with 
multiple male partners 
and has had unprotected 
anal sex? 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
Retention Confidence 
to prescribe PrEP to a 
person who has 
injected drugs in the 







Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
1, not at all confident; 2, slightly 
confident; 3, moderately confident; 4, 
extremely confident 
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   person who has injected 
drugs in the past 6 




to prescribe PrEP to a 
person who has been 
on methadone 
maintenance for the 







Assuming a recent 
negative HIV test and 
equal access to 
medication, how 
confident are you to 
prescribe PrEP to a 
person who has been on 
methadone maintenance 
for the past 6 months 
but has continued 
injection drug use? 
1, not at all confident; 2, slightly 






Total score of all post 
Confidence related 
responses 
Total possible points 8 to 32 numeric 
points 
Retention survey- 
Likeliness to prescribe 
PrEP in next 6 months 
Re_prescribe Ordinal Retention survey item: 
How likely are you to 
prescribe PrEP in the 
next 6 months? 
1, not at all; 2, slightly; 3, moderately; 
4, extremely 




Table 3. PrEP Education Intervention’s Budget 
 
Necessary Items Item Cost Total Cost $ 
Survey Collection Platform $276 – annual subscription $276 
Subject Incentive (Target) $20 – each gift card X 5 $100 




SPSS 27 subscription $99 $ 99 
  $975 




Participant Characteristics and Prior Experiences 
Table 4. Sociodemographic Characteristics of Participants at Baseline 
 n (%) 
Participants 39 (100) 
Employment status  
Full Time 34 (87.2) 
Regular Part Time 1 (2.6) 
Casual/Committed Part 3 (7.7) 
Time 1 (2.6) 
Gender  
Male 1 (2.6) 
Female 38 (97.4) 
Race  
African American or Black 11 (28.2) 
Asian 10 (25.6) 
Hispanic or Latino 1 (2.6) 
White/ Non-Hispanic 14 (35.9) 
Other 3 (7.7) 
Nursing Education Level  
MSN or master’s degree 30 (76.9) 
DNP/ Doctorate 9 (23.7) 
 M (SD) 
Age 38.79 (8.89) 1 
Years’ Experience 6.35 (8.98) 
1 Five subjects missing data 
 
Note. This table depicts demographics for all 39 participants of the PrEP education intervention. 
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Table 5. Prior Experiences with PrEP 
 
Items n (%) 
Heard about PrEP?  
Yes 38 (97.4) 
No 1 (2.6) 
Ever asked a Patient about PrEP?  
Yes 25 (65.8) 
No 14 (35.9) 
Ever initiated a patient conversation about PrEP?  
Yes 19 (48.7) 
No 20 (51.3) 
Ever prescribed PrEP?1  
Yes 20 (51.3) 
No 18 (46.2) 
Before today, how would you rate your knowledge of  
PrEP’s potential side effects? 0 (0%) 
Excellent 3 (7.9) 
Very Good 14 (36.8) 




1 Does not equal 100% due to missing data 
 
Note. Participants’ prior experiences with PrEP are being described in percentages. The 
 
knowledge rating question regarding his or her knowledge of PrEP was based on a 5-point Likert 
 
Scale. Percentage breakdowns highlight that less than 50% of participants had baseline rating of 
 
“Good” or “Very Good” prior to the education tutorial. 




Table 6. Paired t-Tests for Pre and Post Survey Results 
 
 Post  Pre   
 M SD n M SD N t df p 
95% CI 
Lower Upper 
Knowledge 8.10 1.651 39 6.44 1.373 39 5.159 38 <.001 1.013 2.321 
Comfort 11.74 3.142 38 9.97 3.412 38 2.827 37 .008 .500 3.027 
Confidence 24.18 5.703 39 19.54 6.786 39 4.516 38 <.001 2.561 6.721 
 
Note. This table demonstrates the mean scores for all constructs for the pre- and post-survey 
items. There were significant mean differences between pre-survey scores compared with post- 
survey scores for all constructs. The mean scores for the construct that explored comfort 
identifying “at-risk HIV individuals” was also found to be significant. 




Knowledge Mean Scores 




















Note. This figure depicts the mean score differences across the three survey phases for the 
knowledge about PrEP clinical practice. Each survey’s total possible knowledge score was 10 
points for the ten PrEP related knowledge questions. 
10.00 

























Knowledge Mean, SD, and ANOVA 
Table 7. Mean and SD for Knowledge of PrEP Clinical Practice 
Knowledge of PrEP clinical practice 
 M SD N 
PreKscore 6.23 1.359 31 
PostKscore 8.13 1.648 31 
ReKscore 7.19 1.778 31 
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Sum Squares Df 
Mean 
Square p F 
P 
Eta2 









95% Confidence Interval 
for Difference a 
Lower Upper 
Pre vs Post -1.903* .366 <.001 -2.83 -.975 
Pre vs Retention -.968* .333 .020 -1.81 -.124 
Post vs Retention .939* .385 .064 -.041 1.912 
*p ≤ 0.05, a Bonferroni post-hoc 
 
Note. This table demonstrates the pairwise mean differences for the repeated measures of the 
knowledge construct’s total composite scores. The average mean score for 31 participants for 
each survey was analyzed. The postKscore and preKscore mean differences were significantly 
different. The ReKscore was also significantly different from the PreKscore. There was no 
significant difference between the ReKscore and PostKscore. 
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Appendix R 
Comfort Mean Scores 




















Note. This figure depicts the difference in mean rating scores across the three survey points for 
the comfort construct which measured the comfort level associated with identifying “at-risk 
HIV” individuals. The survey consisted of 16 possible points for the four items related to 



























Comfort Mean, SD, and ANOVA 
Table 9. Mean and SD for Comfort Identifying “At-Risk HIV Patients” 
Comfort Screening “At-risk HIV Patients” 
 M SD N 
PreComfscore 10.00 3.572 30 
PostComfscore 11.67 3.377 30 
ReComfscore 12.50 1.961 30 
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df Mean Square p F P Eta
2 
















Pre vs Post -1.667 .715 .081 -3.483     .150 
Pre vs Retention -2.500* .612 .001 -4.054     -.946 
Post vs Retention -.833 .541 .402 -2.207     .540 
*p ≤ 0.05, a Bonferroni post-hoc 
 
Note. This table demonstrates the pairwise mean differences for the repeated measures of the 
comfort construct’s total composite scores. The average score for the 30 participants were 
analyzed for the three surveys. The means for PreComfscore and PostComfscore were not 
significantly different. However, the mean score was significant when ReComfscore was 
compared to the PreComfscore, PostComfscore, and ReComfscore were not significantly 
different. 
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Appendix T 
Confidence Mean Scores 



















Note. This figure depicts the difference in mean rating scores across the three survey points for 
the confidence with PrEP prescribing practices. This construct consisted of eight questions with 
a 4-point Likert Scale answers. There were 32 possible points for the eight items related to 

























Confidence Mean, SD, and ANOVA 
Table 11. Mean and SD for Confidence to Prescribe PrEP 







PreConScore 19.65 6.993 31 
PostConScore 24.90 5.473 31 
ReConScore 25.48 4.122 31 
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Table 12. Repeated measures ANOVA – Confidence to Prescribe PrEP 
 
 
Sum Squares Df Mean Square p F P Eta
2 









95% Confidence Interval 
for Difference a 
Lower Upper 
Pre vs Post -5.258* .986 .001 -7.758 -2.758 
Pre vs Retention -5.839* 1.53 .001 -8.762 -2915 
Post vs Retention -.581 .796 .999 -2.600 1.438 
*p ≤ 0.05, a Bonferroni post-hoc 
 
Note. This table demonstrates the pairwise mean differences for the repeated measures of the 
confidence construct’s total composite scores. Significant mean differences with p<.05 are 
notable between PreConScore and PostConScore as well PreConScore and ReConScore. There 
was no significant mean difference between PostConScore and ReConScore. 




All Constructs Mean Scores 



















Note. This figure represents the mean ratings that was notable for the presurvey, postsurvey and 
retention survey results. The mean scores for PrEP clinical practice knowledge, comfort 
identifying at-risk HIV patients, and confidence with PrEP prescribing practices are depicted at a 












Knowledge Comfort Confidence 
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Appendix W            
Likeliness to Prescribe 






















Note. This figure demonstrates the mean rank for the question, “How likely are you to 
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Appendix X  
Friedman’s ANOVA 
Table 13. Pairwise Comparison for Friedman’s ANOVA 
 
  
N Χ2 df Asymptotic Sig. (2-sided test) 
Friedman’s  30 22.448 2 <.0001 
Likeliness to 
Prescribe in next 
six months 
 




Sig. Adj. Siga 
Pre vs Post .650* .258 2.517 .012 .035 
Pre vs Retention .800* .258 3.098 .002 .006 
Post vs Retention -.150 .258 -.581 .561 .999 
*p ≤ 0.05, a Bonferroni post-hoc 
Note. This table demonstrates the changed likeliness to prescribe ratings for the three 
surveys administered. The result indicated that likeliness to prescribe in next six months at 
baseline pre- survey was significantly different from post-survey and pre-survey from 
retention survey. However, likeliness to prescribe for retention survey was not significantly 
different from post- survey. 
